Page last updated: 2024-08-24

lamivudine and guanine

lamivudine has been researched along with guanine in 539 studies

Research

Studies (539)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (2.04)18.2507
2000's156 (28.94)29.6817
2010's350 (64.94)24.3611
2020's22 (4.08)2.80

Authors

AuthorsStudies
Korba, BE1
Boyd, MR; Korba, BE1
Colledge, D; Locarnini, S; Shaw, T1
Fontana, RJ; Lok, AS1
Jaeckel, E; Manns, MP1
Chen, FC; Flavin, MT; Korba, BE; Lin, YM; Zembower, DE1
Cheng, YC; Fu, L; Liu, SH1
Carrilho, FJ; Kato, N; Lan, KH; Omata, M; Ono-Nita, SK; Shiratori, Y; Yoshida, H1
Keating, MR1
Civitico, G; Colledge, D; Locarnini, S; Shaw, T1
De Clercq, E; Neyts, J; Ying, C1
Cheng, YC; Fu, L1
Arnold, E; Das, K; Gibbs, CS; Sarafianos, SG; Westland, CE; Xiong, X; Yang, H1
de Man, RA; Niesters, HG; Wolters, LM1
Boyer, N; Castelneau, C; Marcellin, P1
Colonno, RJ; Hernandez, D; Levine, S; Rose, R; Weinheimer, S; Yamanaka, G; Zhang, S1
Lok, AS2
Anderson, FH; Dehertogh, D; Lai, CL; Lao, J; Rosmawati, M; Thomas, N; Van Vlierberghe, H1
Burroughs, AK; Papatheodoridis, GV; Sevastianos, V1
Iino, S2
Addison, WR; Allen, MI; Condreay, LD; Tipples, GA; Tyrrell, L; Walters, KA1
Buster, EH; Schalm, SW; van der Eijk, AA1
Ala, A; Dieterich, DT1
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A1
Locarnini, S1
Angus, P; Ayres, A; Bartholomeusz, A; Colonno, RJ; Discotto, L; Levine, SM; Locarnini, S; Plym, M; Pokornowski, K; Rose, RE; Sievert, W; Tenney, DJ; Thompson, G; Walsh, AW; Warner, N; Weinheimer, SP; Yu, CF1
Fujiwara, K; Mochida, S1
Yoshiba, M1
Gunji, T; Omata, M1
Ariksoysal, DO; Erdem, A; Karadeniz, H; Ozsoz, M; Sayiner, AA; Sengonul, A1
Leung, N2
Bacon, BR; Chang, TT; Cianciara, J; Colonno, RJ; Gish, RG; Hadziyannis, SJ; Hindes, RG; Joshi, S; Klesczewski, KS; Pastore, G; Poynard, T; Rizzetto, M; Rose, RE; Schiff, ER; Thiry, A1
Rivkin, A1
Asselah, T; Castelnau, C; Marcellin, P1
Roche, B; Samuel, D1
Apelian, D; Chang, TT; Chao, YC; Colonno, R; Cross, A; de Man, R; DeHertogh, D; Gadano, A; Gish, RG; Goodman, Z; Han, KH; Lok, AS; Sollano, J; Wilber, R; Zhu, J1
Chang, TT; Cheinquer, H; Colonno, R; Cross, A; DeHertogh, D; Fernandes, L; Goodman, Z; Lai, CL; Lok, AS; Shouval, D; Wilber, R; Zink, RC1
Asselah, T; Boyer, N; Marcellin, P1
Sherman, M1
Lok, AS; Osborn, MK1
Schiff, ER; Schreibman, IR1
Feng, B; Wei, L1
Hou, JL; Zeng, GB1
Halota, W; Pawłowska, M1
Boron-Kaczmarska, A; Cianciara, J; Colonno, R; Cross, A; Denisky, G; Goodman, Z; Hindes, R; Kreter, B; Liaw, YF; Martin, P; Sherman, M; Silva, M; Sollano, J; Yurdaydin, C1
Chang, TT; Lai, CL1
Hollinger, FB; Lau, DT1
Hadziyannis, SJ3
Grant, RM; Levy, V1
Trautwein, C1
Benhamou, Y1
Colonno, R; De Clercq, E; Neyts, J; Ying, C1
Sims, KA; Woodland, AM1
Baldick, CJ; Colonno, RJ; Eggers, B; Fang, J; Hsu, M; Klesczewski, K; Levine, S; Mazzucco, C; Plym, M; Pokornowski, K; Rose, R; Tenney, DJ; Walsh, A; Yu, CF; Zhang, S1
Dienstag, JL; Kreter, B; Wei, LJ; Xu, D1
Baldick, CJ; Colonno, RJ; Eggers, B; Fang, J; Hsu, M; Levine, SM; Mazzucco, CE; Plym, MJ; Pokornowski, KA; Poundstone, P; Rose, RE; Tenney, DJ; Walsh, AW; Yang, J; Yu, CF; Zhang, S1
Keeffe, EB; Marcellin, P1
Barraud, L; Ollivet, A; Pichoud, C; Trépo, C; Villeneuve, JP; Villet, S; Zoulim, F1
Ren, H; Shi, XF; Wang, ZY; Zhang, DZ; Zhou, Z1
Liaw, YF1
Fung, J; Lai, CL; Ngai, VW; Wong, DK; Yuen, MF1
Chen, CW; Hou, JL; Tan, DM; Wang, YM; Xu, DZ; Yao, GB; Zhu, M1
Lok, AS; Tan, J1
Gish, RG1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Watahiki, S; Yatsuji, H1
Koike, K; Yotsuyanagi, H2
Abe, H; Aimitsu, S; Aisaka, Y; Chayama, K; Fujimoto, Y; Hatakeyama, T; Hiraga, N; Imamura, M; Kawakami, H; Kawakami, Y; Kohno, H; Maekawa, T; Mori, N; Noguchi, C; Ochi, H; Takahashi, S; Tsuge, M; Yatsuji, H1
Calleja, JL; Peñas, B2
Yao, G1
Bhat, S; Brennan, TP; Chong, CR; Hale, B; Hegarty, R; Jilek, BL; Liu, JO; McMahon, MA; Shen, L; Siliciano, RF; Thio, CL; Wind-Rotolo, M; Xing, S; Zhou, Y1
Garcia-Gasco, P; Sheldon, J; Soriano, V1
Arora, G; Keeffe, EB1
Jia, JD; Li, HY; Liang, L; Ma, H; Ren, JB; Sun, SJ; Wang, RL; Wang, Y1
Piao, DM; Piao, XX; Ren, FY1
Buti, M; Elefsiniotis, I; Esteban, R; Gimferrer, M; Jardi, R; Rodriguez-Frias, F; Schaper, M; Tabernero, D1
Niederau, C1
Okanoue, T1
Abiru, S; Nagaoka, S; Yatsuhashi, H1
Orito, E1
Shiryu, H; Suzuki, F; Tanaka, E; Tanaka, Y1
Fukushima, K; Inoue, J; Kogure, T; Nagasaki, F; Niitsuma, H; Shimosegawa, T; Ueno, Y1
Abe, H; Chayama, K; Fujimoto, Y; Hatakeyama, T; Hiraga, N; Imamura, M; Kumada, H; Maekawa, T; Mori, N; Ochi, H; Suzuki, F; Takahashi, S; Tsuge, M; Yatsuji, H1
Fung, J; Lai, CL; Mizokami, M; Tanaka, Y; Wong, DK; Yuen, MF1
Clarke, L; Di Bisceglie, A; Gish, RG; Iloeje, UH; Kowdley, KV; Sullivan, SD; Tafesse, E; Veenstra, DL1
Brett-Smith, H; Chang, TT; Chao, YC; Colonno, R; de Man, RA; Gadano, A; Gish, RG; Han, KH; Harris, M; Lee, SD; Lok, AS; Sollano, J; Yang, J1
Keeffe, EB1
Chayama, K; Takahashi, S1
Buti, M; Elefsiniotis, I; Esteban, R; Jardi, R; Rodriguez-Frias, F; Ruiz, G; Schaper, M1
de Man, RA; Leemans, WF; Ter Borg, MJ1
Janssen, HL; Reijnders, JG1
Sánchez-Tapias, JM1
Ikeda, K1
Baldick, CJ; Colonno, RJ; Eggers, BJ; Fang, J; Levine, SM; Pokornowski, KA; Rose, RE; Tenney, DJ; Yu, CF1
Bisceglie, A; Di Bisceglie, A; Gish, RG; Kowdley, KV; Spackman, DE; Veenstra, DL1
Degertekin, B; Lok, AS1
Audsley, J; Baden, R; Caro, J; Hunter, H; Lewin, SR; Matthews, G; McMahon, MA; Mijch, A; Olender, SA; Sasadeusz, J; Siliciano, RF; Thio, CL1
Ayoub, WS; Keeffe, EB1
Girke, J; Manns, MP; Tillmann, HL; Wedemeyer, H; Wiegand, J1
Flisiak, R; Jaroszewicz, J1
Hindes, R; Kreter, B; Liaw, YF; Rustgi, VK; Sette, H; Sherman, M; Silva, M; Simsek, H; Tenney, DJ; Tsai, N; Vaughan, J; Yurdaydin, C1
Imazeki, F; Kage, M; Katano, Y; Kumada, H; Moriyama, M; Omata, M; Sata, M; Seriu, T; Suzuki, F; Toyoda, J1
Harrison, TJ; Ijaz, S; Moore, PL; Sloan, RD; Tedder, RS; Teo, CG1
Bläckberg, J; Duberg, AS; Fischler, B; Friman, S; Karlström, O; Lindh, M; Norkrans, G; Reichard, O; Sangfeldt, P; Söderström, A; Sönnerborg, A; Uhnoo, I; Weiland, O; Wejstål, R; Wiström, J1
Cheong, JY1
Yim, HJ1
de Man, RA; Janssen, HL; Leemans, WF; Niesters, HG; Schalm, SW; van der Eijk, AA1
Itoh, A; Naoki, H; Sugiura, K; Sugiura, M; Takashi, T1
Brett-Smith, H; Chao, YC; Goodman, Z; Han, SH; Janssen, HL; Lee, WM; Schiff, E; Sette, H; Simsek, H; Tamez, R; Yang, J1
Brandão-Mello, CE; Brett-Smith, H; Cassetti, I; Gazzard, B; Hall, A; Huang, AK; Mendes-Corrêa, MC; Pessôa, MG; Phiri, P; Soriano, V1
Beckebaum, S; Cicinnati, VR; Gerken, G; Sotiropoulos, GC1
Desmond, P; Locarnini, S; Nguyen, T1
Feng, T; Guo, JJ; Huang, AL; Li, QL; Shi, XF; Zeng, AZ; Zhang, DZ1
Lee, SD; Su, CW; Wu, JC1
Degertekin, B; Hussain, M; Lok, AS; Oberhelman, K; Tan, J1
Brett-Smith, H; Carosi, G; Chang, TT; Cheinquer, H; Han, S; Kaymakoglu, S; Lai, CL; Martin, P; Shouval, D; Tamez, R; Tenney, D; Yang, J1
García Buey, L; González Mateos, F; Moreno Otero, R1
Buti, M2
Sarmento E Castro, R; Sheldon, J; Soriano, V1
González-Diéguez, ML; Rodríguez, M1
Barreiro, P; García-Samaniego, J; Martín-Carbonero, L1
Augustovski, F; Calcagno, JI; Gadano, A; Souto, A; Yuan, Y1
McMahon, B; Scott, JD1
Chien, RN; Liaw, YF1
Buster, EH; Janssen, HL; Schalm, SW1
Colombo, M; Lampertico, P1
Araujo, ES; Costa, AM; L 'italien, G; Nita, ME1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Miyakawa, Y; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H1
de Man, RA; Janssen, HL; Pas, SD; Reijnders, JG; Schutten, M1
Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Sheldon, J; Tacke, F; Trautwein, C1
Baldick, CJ; Colonno, RJ; Eggers, BJ; Fang, J; Pokornowski, KA; Rose, RE; Tenney, DJ; Wichroski, MJ; Wilber, RB; Xu, D; Yang, J1
Ham, MY; Holt, C; Saab, S; Stone, MA; Tong, M1
Dai, YX; Ding, H; Hu, TH; Huang, LH; Jiang, XH; Jiang, YM; Qiu, YW; Zhou, M1
Chiba, T; Ichinohe, T; Kadowaki, N; Marusawa, H; Uchiyama, T; Ueda, Y1
Angus, PW; Patterson, SJ1
Borroto-Esoda, K; Curtis, M; Miller, MD; Qi, X; Zhu, Y1
Arnold, E; Cook, G; Iloeje, U; Yuan, Y1
Buti, M; Córdoba, J; Esteban, R; García-Martínez, R; Les, I; Quintana, M1
Baldick, CJ; Colonno, RJ; Fang, J; Kienzle, BK; Levine, SM; Mazzucco, CE; Pokornowski, KA; Rose, RE; Tenney, DJ; Walsh, AW; Wichroski, MJ1
Buffet, C1
Bessone, F; Brett-Smith, H; Chang, TT; Chao, YC; Cheinquer, H; de Man, R; Gish, RG; Gorbakov, VV; Han, KH; Tamez, R1
Doi, Y; Fukuda, K; Fukui, H; Hayashi, N; Hiramatsu, N; Imai, Y; Kanto, T; Kasahara, A; Kashihara, T; Kato, M; Kiso, S; Kurashige, N; Mita, E; Mochizuki, K; Nagase, T; Ohkawa, K; Oshita, M; Oze, T; Takehara, T; Yakushijin, T; Yamada, A; Yoshihara, H1
Gong, QM; Han, Y; Huang, LH; Jin, GD; Kong, XF; Li, J; Lin, ZM; Liu, CM; Lu, ZM; Yang, S; Yu, DM; Zhang, DH; Zhang, XX1
LI, H; REN, H; SHI, XF; WANG, ZY; ZHANG, DZ; ZHOU, Z1
Aoki, T; Fujiwara, H; Iwama, K; Kimura, S; Matsue, K; Odawara, J; Takeuch, M; Yamakura, M1
Brett-Smith, H; Chang, TT; de Man, R; Gadano, A; Gish, RG; Lai, CL; Poordad, F; Tamez, R; Yang, J1
Cong, M; Jia, J; Li, H; Liu, T; Ma, H; Ou, X; Ren, J; Wang, B; Wang, P; Wang, X; You, H1
Chung, YH; Kim, KM; Lee, HC; Lee, YS; Lim, YS; Shim, JH; Suh, DJ1
Mullen, JE; Tong, CY; Wong, T1
Cheong, JY; Cho, SW; Hong, SP; Kim, SO; Koh, KH; Lee, MH; Yoo, WD1
Ahn, SH; Chon, CY; Han, KH; Hong, SP; Kim, DY; Kim, HJ; Kim, JK; Lee, CK; Lee, HW; Lee, JM; Lee, KS; Nguyen, T; Paik, YH; Park, JY1
Barreiro, P; Fernández, JV; Labarga, P; Medrano, J; Soriano, V; Tuma, P; Vispo, E1
Akhan, SC; Cekmen, M; Hülagü, S; Meriç, M; Sayan, M; Sentürk, O1
Lin, Q; Zhang, DZ1
Chen, XS; Han, LZ; Luo, Y; Qiu, DK; Shen, CH; Wang, SY; Wang, X; Xi, ZF; Xia, Q; Xin, TY; Zhang, JJ1
Byun, KS; Choe, WH; Hong, SP; Ji, SI; Jung, YK; Kim, BK; Kim, JH; Kim, KH; Kim, SO; Ko, SY; Kwon, SY; Lee, CH; Yeon, JE1
Baqai, S; Inoue, M; Karino, Y; Kurbanov, F; Lai, CL; Mizokami, M; Mukaide, M; Orito, E; Sakaguchi, K; Sata, M; Shin-I, T; Tanaka, Y; Yamada, G; Yokosuka, O; Yuen, MF1
Deng, LN; Hou, HB; Li, CP; Liu, FQ; Liu, XR1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I1
Chen, CW; Jia, JD; Ren, H; Wang, YM; Xu, DZ; Yao, GB; Zhou, XQ2
Duong, A; Mousa, SA1
Han, KH; Kim, CR; Kim, HR; Kim, J; Lai, CL; Um, SH; Yoon, SK; Yuen, MF1
Marcellin, P; Piratvisuth, T; Sung, J1
Colonno, RJ; Langley, DR; Tenney, DJ; Walsh, AW1
Buti, M; Deterding, K; Hansen, BE; Janssen, HL; Petersen, J; Reijnders, JG; Santantonio, T; van Bömmel, F; Wedemeyer, H; Zoulim, F1
Topalak, O; Ustundag, Y1
Abe, H; Chayama, K; Chen, DS; Hatakeyama, T; Hu, JT; Huang, YW; Kao, JH; Lai, MY; Liu, CJ; Takahashi, S; Tsuge, M; Yang, SS1
Chee, GM; Poordad, F1
Jiang, L; Yan, LN1
Cui, YL; Feng, P; Lei, XZ; Liu, L; Song, XQ; Tang, H; Wang, YB; Yan, F; Zheng, MH1
Bao, H; Furman, PA; Korba, B; Micolochick Steuer, HM; Murakami, E; Niu, C; Tolstykh, T1
Chien, RN2
Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Watahiki, S; Yatsuji, H1
Bock, T; Karlas, T; Krasselt, U; Mössner, J; Schiefke, I; Tillmann, HL; Wiegand, J1
Chen, H; Li, T; Shen, J; Wu, B1
Chan, TM; Choy, BY; Tang, CS; Yap, DY; Yuen, MF; Yung, S1
Choi, JJ; Jang, H; Kim, J; Park, H; Son, Y1
Chen, L; Liu, Y; Ren, X; Si, L; Wang, Y; Xu, D; Xu, T; Xu, Z; Zhao, J; Zhong, Y1
Li, JG; Liu, L; Tang, YZ; Wang, XH; Wang, YM; Zhou, JJ1
Einarson, TR; Heathcote, EJ; Kowgier, M; Krahn, M; Nishikawa, Y; Pham, B; Sherman, M; Tomlinson, G; Ungar, WJ; Wong, DK; Woo, G1
Chae, HB; Goo, JC; Hong, SP; Jeong, JI; Kim, BU; Kim, SO; Park, BC; Park, SM; Youn, SJ1
Coffin, CS; Michalak, TI; Mulrooney-Cousins, PM; Peters, MG; Roberts, JP; Terrault, NA; van Marle, G1
Chung, YH; Heo, NY; Lee, HC; Lee, YS; Lim, YS; Suh, DJ1
Cho, YK; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JH; Sohn, CI1
Gong, HY; Liu, ZG; Zhang, HY; Zhang, Z1
Dakin, H; Fidler, C; Harper, C1
Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H1
Einecke, D1
Ahn, SH; Chon, CY; Han, KH; Kim, DY; Lee, JM; Lee, MH; Park, JY; Ryu, HJ1
Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Tacke, F; Trautwein, C1
Chotiyaputta, W; Ditah, FA; Goodwin, D; Lok, AS; Peterson, C1
Jiang, Y; Li, W; Liu, J; Niu, J; Sun, P; Xin, G; Xu, D; Yan, H; Yu, L; Zhang, H1
Egashira, T; Kobayashi, M; Kumada, H; Nagano, M; Suzuki, F; Tadokoro, K; Yamaguchi, T1
Chan, HL; Chan, HY; Chim, AM; Chu, SH; Sung, JJ; Wong, GL; Wong, VW; Yiu, KK1
Guo, CC; Guo, HQ; Huang, JJ; Huang, Y; Li, HR; Lin, TY; Pu, XX; Xie, Y; Zhai, LZ; Zhang, X; Zhu, HL1
Bourlière, M; Kahloun, A; Zoulim, F1
Benhamou, Y; Pais, R1
Marcellin, P1
Abuduheilili, X; Dong, JP; Hou, CS; Jiao, XJ; Li, T; Li, XG; Liu, BM; Sun, XW; Wang, YH; Xu, J; Yan, CH; Yan, L; Yang, JX; Zhuang, H1
Chen, L; Ji, D; Li, X; Liu, Y; Wang, C; Wang, H; Xin, S; Xu, D; Zhong, Y; Zoulim, F1
Bartels, M; Berg, T; Hartmann, J; Jonas, S; Karlas, T; Maier, M; Mössner, J; Tillmann, HL; Weimann, A; Wiegand, J1
Bae, SH; Baek, YH; Han, SY; Lee, SW1
Chen, J; Chen, JM; Ding, JB; Du, N; Duan, XZ; He, WP; Hu, JH; Huang, K; Liu, XY; Wang, HF1
Papatheodoridis, GV1
Zoulim, F1
Mallet, V; Pol, S; Vallet-Pichard, A1
Chung, GE; Hwang, SY; Jeong, JB; Jung, YJ; Kim, BG; Kim, D; Kim, HY; Kim, W; Kim, YJ; Lee, HS; Lee, JH; Lee, KL; Yoon, JH1
Cao, H; Chen, LB; Chen, N; Li, G; Shu, X; Xu, QH; Zhang, K; Zhang, YF1
Chen, L; Chen, R; Deng, L; Gong, QM; Huang, SY; Jiang, Y; Liu, F; Yu, DM; Yu, JL; Zhang, XX1
Ikeda, F; Kobashi, H; Yamamoto, K1
Akaike, J; Arakawa, T; Karino, Y; Kimura, M; Kuwata, Y; Nakajima, T; Ohmura, T; Ozeki, I; Sato, T; Toyota, J1
Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A1
Ahn, SH; Cho, SW; Choi, SH; Hahn, JS; Han, KH; Hong, SP; Kim, SO; Shin, SK1
Awen, BZ; Challa, BR; Chandu, BR; Rihanaparveen, S1
Cheng, C; Fung, J; Hung, IF; Lai, CL; Seto, WK; Wong, DK; Wu, R; Yuen, J; Yuen, MF1
Beebe, S; Bialkowska, J; Brown, RS; Cheinquer, H; Cooney, E; Jeffers, L; Leung, N; Liaw, YF; Myers, RP; Peng, CY; Raptopoulou-Gigi, M; Sarin, SK; Tang, S; Tanwandee, T; Tsai, N1
Cong, M; Jia, J; Liu, T; Ma, H; Ou, X; Wang, B; Wang, P; Wang, Q; Wu, X; You, H1
Tornai, I1
Minami, M; Okanoue, T2
Ji, Y; Jiang, H; Ju, L; Kan, N; Wu, K; Yu, M1
Chan, HL; Ge, S; Guo, W; Hu, J; Huang, X; Jiang, J; Jiang, Z; Liang, Y; Liu, Z; Su, M; Wong, VW; Xie, R; Zhu, M1
Chan, AC; Chan, SC; Chok, KS; Fan, ST; Lo, CM; Poon, RT; Yuen, WK1
Benetti, S; Cassino, L; Fay, F; Quarleri, J; Tanno, H1
Cho, EJ; Hwang, SY; Jang, ES; Kim, CY; Kim, YJ; Kwak, MS; Lee, CH; Lee, HS; Lee, JH; Yang, HJ; Yoon, JH; Yu, SJ1
Block, TM; Clearfield, E; Cuconati, A; Goddard, C; Guo, H; Mills, C; Morrey, JD; Motter, NE; Xiao, T; Xu, X; Yu, W; Zhao, K1
Giles, M; Sasadeusz, J; Visvanathan, K1
Hu, HD; Hu, P; Liu, JY; Ren, H; Sheng, YJ; Tong, SW; Zhang, DZ1
Chan, HL; Chan, HY; Ong, A; Tse, CH; Wong, GL; Wong, VW1
Cho, YS; Choi, JW; Kim, KA; Kwak, MS; Lee, CK; Lee, JS; Park, BK; Suh, JH; Won, SY1
Jang, JS; Jang, MK; Kim, DJ; Kim, HS; Kim, HY; Kim, KH; Lee, JH; Lee, MS; Park, CK; Park, JW; Seo, DD; Shin, WG1
Razonable, RR1
Chen, T; He, Y; Liu, H; Liu, X; Wang, K; Yan, Z; Zhang, S; Zhao, Y1
Cheong, JY; Cho, SW; Hong, SP; Kim, SO; Kim, SS; Lee, D; Lee, MH1
Lee, SS; Sherman, M1
Bozdayi, AM; Cinar, K; Gokahmetoglu, S; Güven, K; Idilman, R; Karatayli, E; Karatayli, SC; Yurdaydin, C1
Chuma, M; Hige, S; Nakanishi, M; Sho, T1
Cao, Z; Chen, X; Jin, Y; Liu, Y; Ma, B; Ma, L; Wu, H; Yu, H; Zhang, H; Zhang, Y; Zheng, Y1
An, H; Byun, KS; Hyun, JJ; Jung, ES; Kang, HS; Kim, CD; Kim, DJ; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yoon, E1
Dalekos, GN; Tillmann, HL; Zachou, K1
García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V1
Cha, JM; Jeon, JW; Joo, KR; Kim, S; Lee, JI; Lim, JU; Lim, K; Park, JJ; Shin, HP1
Chow, PY; Lee, KK; Lee, VW; Li, H; Wu, DB1
Arai, M; Fujiwara, K; Goto, N; Imazeki, F; Kamezaki, H; Kanda, T; Nakamoto, S; Shinozaki, M; Wu, S; Yokosuka, O1
Kim, YJ; Lee, HS; Lee, JH; Yang, HJ; Yoon, JH1
Fontana, RJ; Singal, AK1
Fujimori, M; Kumada, T; Sone, Y; Tada, T; Toyoda, H1
Heo, NY; Lee, HC; Lee, TH; Lim, YS; Shim, JH; Suh, DJ1
Chang, J; Chen, PJ; Han, SY; Hsiao, CC; Liu, WH; Wu, JY; Yeh, SH1
Chang, CY; Hsu, CC; Hsu, CY; Hsu, YC; Huang, SC; Lin, CW; Lin, JT; Lo, GH; Mo, LR; Perng, DS; Tai, CM; Tseng, CH1
Chang, MH; Changchien, CS; Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E1
Lee, D; Lee, HC; Lee, JY; Lee, YS; Lim, YS; Shim, JH; Suh, DJ2
Han, T; Li, J; Li, Y; Liu, L; Xiao, SX; Xing, J1
Ahn, SH; Chon, CY; Han, KH; Kim, DY; Lee, JM; Lee, MH; Park, JY; Ryu, HJ; Son, CY1
Ahn, SH; Baatarkhuu, O; Chon, CY; Han, KH; Kim, DY; Kim, SU; Park, JY; Shin, HS1
Fernandes, CA; Gomes, Sde A; Mello, FC1
Chang, KC; Chen, TC; Chen, YT; Chien, YS; Chiu, KW; Hu, TH; Lin, MT; Tsai, MC1
Chiba, T; Fujiwara, T; Kou, T; Marusawa, H; Nasu, A; Nishijima, N; Osaki, Y; Shimizu, K; Takahashi, K; Tsuchiya, S; Ueda, Y; Uemoto, S; Yazumi, S1
Cha, BK; Chang, HY; Chang, SK; Choi, CH; Do, JH; Hong, SP; Kim, HJ; Kim, JG; Lee, HW1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Goulis, I; Papanikolaou, V; Vasiliadis, T1
Cho, MH; Cho, SM; Choe, BH; Chu, M; Kwon, S; Lee, WK1
Almasio, PL; Bertino, G; Brandolino, N; Bruno, S; Caroleo, B; Cosco, L; Di Marco, V; Foti, G; Frugiuele, P; Galdieri, A; Madonia, S; Montalto, G; Portelli, V; Russello, M; Sapienza, M; Scifo, G; Siciliano, R; Spadaro, A; Stroffolini, T; Surace, L1
Diao, S; Ha, M; Huang, C; Huang, Z; Lin, M; She, H; Shen, L; Shen, W; Sun, L; Wu, J; Zhang, G1
Ko, SY; Lee, HC; Lee, JE; Oh, HB; Park, CW1
Alfieri, A; Boni, C; Brancaccio, G; Colombo, M; Ferrari, C; Gaeta, GB; Giuberti, T; Laccabue, D; Lampertico, P; Missale, G; Pesci, M; Schivazappa, S; Viganò, M1
Huang, Y; Wang, J; Wang, M1
Ahn, SH; Cho, M; Han, KH; Heo, J; Kim, DY; Lee, HJ; Park, JY; Park, SY; Seo, YS; Tak, WY; Um, SH; Yoon, KT1
Bozdayi, AM; Cevik, E; Idilman, R; Kabaçam, G; Karatayli, E; Karatayli, SC; Seven, G; Yakut, M; Yurdaydin, C1
Huang, L; Li, T; Wang, C; Xu, D; Zhao, P1
Baxa, DM; Borroto-Esoda, K; Chappell, BJ; Golembieski, A; Gordon, SC; Jovanovich, J; Kizy, A; Krishnan, PV; Sharif, O; Shetron-Rama, L; Snow-Lampart, A; Thekdi, AD1
Aung, MO; Dan, YY; Lee, GH; Lee, YM; Lim, K; Lim, SG; Low, HC; Mak, B; Tan, PS; Thwin, MA1
Alberti, A; Campagnolo, D; Erne, EM; Mirandola, S; Romualdi, C; Rossi, C; Sebastiani, G; Tempesta, D; Vario, A; Velo, E1
Akbal, E; Akin, E; Alkan, E; Ataseven, H; Aygün, C; Başar, O; Baykal, O; Coban, S; Demir, M; Gülşen, MT; Ibiş, M; Koçkar, MC; Köklü, S; Köksal, AŞ; Küçükazman, M; Nadir, I; Ozdil, K; Pürnak, T; Tuna, Y; Yildirim, B; Yüksel, I; Yüksel, O1
Baak, BC; Bakker, CM; Beuers, UH; Brouwer, JT; Buster, EH; Drenth, JP; Honkoop, P; Janssen, HL; Kerbert-Dreteler, MJ; Koek, GH; Tan, AC; van der Spek, BW; van Erpecum, KJ; van Hoek, B; van Nieuwkerk, KM; van Soest, H; Vrolijk, JM1
Cheong, JY; Cho, SW; Hong, SP; Kim, SO; Kim, SS1
Andou, Y; Hisanaga, Y; Kanamori, A; Kiriyama, S; Kumada, T; Niinomi, T; Tada, T; Tanaka, J; Tanikawa, M; Toyoda, H; Yamamoto, K; Yasuda, S1
Cho, EJ; Cho, Y; Chung, KH; Jeong, SH; Jin, E; Kim, CY; Kim, JW; Kim, YJ; Lee, DH; Lee, HS; Lee, JH; Yoon, JH; Yu, SJ1
Choi, DJ; Jung, YK; Kim, JH; Kim, YS; Ku, YS; Kwon, OS1
Ahn, SH; Hong, SP; Hwang, SG; Kim, BH; Kim, HS; Kim, IH; Kim, JH; Lee, JI; Lee, JM; Lee, JW; Lee, SH; Lee, SJ; Park, SJ; Park, YM; Seo, YS; Yim, HJ; Yoon, EL1
Deng, X; Liang, J; Tang, YF; Wu, FS1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y1
Bahrami, S; Chevaliez, S; Grare, M; Hézode, C; Pawlotsky, JM1
Buti, M; Petersen, J1
Chavre, SN; Chu, CK; Govindarajan, R; Hung, W; Korba, B; Rawal, RK; Singh, US; Sugiyama, M; Tanaka, Y; Wang, J1
Fu, SY; Huang, G; Lau, WY; Pan, ZY; Shen, F; Wu, MC; Yang, Y; Zhou, WP1
Choi, BS; Choi, SR; Chung, BH; Hong, YA; Kim, YS; Park, CW; Park, HS; Sun, IO; Yang, CW1
Hickey, DP; Raheem, OA1
Baik, SK; Chae, HB; Hong, SP; Kim, CW; Kim, JH; Kim, MY; Kim, YS; Lee, CD; Lee, JI; Lee, JW; Lee, MS; Park, CK; Park, SH; Seo, YS; Um, SH; Yim, HJ; Yoon, EL1
Baietto, L; Boglione, L; Burdino, E; Cariti, G; Cusato, J; D'Avolio, A; De Rosa, FG; Di Perri, G; Ghisetti, V; Gregori, G1
Cui, YJ; Song, ZL; Teng, DH; Zheng, H; Zheng, WP1
Han, SS; Hong, G; Kong, SY; Lee, KB; Lee, KW; Park, KU; Park, SJ; Suh, KS; Yi, NJ1
Beggel, B; Kaiser, R; Neumann-Fraune, M; Pfister, H; Verheyen, J1
Amarapurkar, DN; Patel, N1
Chen, FW; Coyle, L; Jones, BE; Pattullo, V1
Arai, M; Chiba, T; Fujiwara, K; Imazeki, F; Kamezaki, H; Kanai, F; Kanda, T; Maruyama, H; Nakamoto, S; Nomura, F; Wu, S; Yokosuka, O1
Brown, RS; Brubaker, WD; Chang, MS; Emond, JC; Guarrera, JV; Olsen, SK; Pichardo, EM; Rosenthal-Cogan, L; Stiles, JB1
Gan, WQ; Ke, WM; Lai, J; Mai, L; Yan, Y; Zheng, YB1
Arai, M; Goto, N; Imazeki, F; Kamezaki, H; Kanda, T; Kato, K; Kimura, M; Mikami, S; Miyauchi, T; Nakamoto, S; Shinozaki, M; Sugiura, N; Wu, S; Yokosuka, O1
Acalovschi, M; Arama, V; Bjork, S; Kamar, D; Klauck, I; Leblebicioglu, H; Lescrauwaet, B; Marcellin, P; Mauss, S; Morais, E; Sieklucki, J; Simon, K; Usluer, G; Zarski, JP; Zeuzem, S1
Alteri, C; Andreoni, M; Angelico, M; Cento, V; De Sanctis, GM; Gubertini, G; Micheli, V; Parruti, G; Perno, CF; Pollicita, M; Romano, S; Salpini, R; Sarrecchia, C; Svicher, V; Visca, M1
Ahn, SH; Baartarkhuu, O; Chon, CY; Han, KH; Kim, BK; Kim, DY; Kim, JK; Kim, KS; Kim, SU; Park, JY; Park, MS1
Deng, XL; Guo, JJ; Li, QL1
Chan, AC; Chan, SC; Cheung, C; Cheung, TT; Chok, KS; Fan, ST; Fung, J; Lai, CL; Lo, CM; Seto, WK; Sharr, W; Yuen, MF1
Dong, X; Meng, H; Tian, W; Wang, G; Wei, G; Wu, X; Yuchi, J1
Chen, Q; He, LL; Wang, JC1
Terrault, N1
Chan, HL; Chan, HY; Chim, AM; Lo, AO; Tse, CH; Wong, GL; Wong, VW1
Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M1
Horváth, G1
Arase, Y; Ichida, T; Imazeki, F; Ito, K; Karino, Y; Kurosaki, M; Maeshiro, T; Masaki, N; Michitaka, K; Mita, E; Mizokami, M; Murata, K; Saito, T; Sugiyama, M; Takikawa, Y; Tanaka, Y; Tanuma, J; Toyoda, H; Umemura, T; Yamamoto, K; Yatsuhashi, H; Yoneda, M; Yotsuyanagi, H1
Šperl, J1
Guo, JJ; He, S; Li, QL; Zhang, Y1
Alp, A; Aydoğan, S; Balaban, Y; Ergünay, K; Hasçelik, G; Simşek, H; Tatar, G; Us, D1
Kim, DG; Kim, IH; Kim, SH; Kim, SW; Lee, S; Lee, SO; Lee, ST; Seo, SY; Sohn, JY1
Cai, FJ; Ding, JG; Du, QW; Fu, RQ; Hong, L; Sun, QF; Wu, YH; Zhou, QQ1
Bailly, F; Chevallier, P; Egounlety, R; Koffi, J; Lebosse, F; Lussier, V; Pradat, P; Si-Ahmed, SN; Zoulim, F1
Cho, Y; Cho, YY; Choi, WM; Kim, CY; Kim, YJ; Lee, DH; Lee, HS; Lee, JH; Lee, M; Lee, YB; Yoo, JJ; Yoon, JH; Yu, SJ1
Hu, H; Hu, P; Liu, J; Peng, H; Ren, H; Tang, H; Tong, S; Yang, M; Yin, W1
Chen, JY; Hu, JH; Jia, HY; Li, LJ; Lian, JS; Lu, YF; Xiang, DR; Yang, YD; Yu, L; Zeng, LY; Zhang, YM; Zheng, L1
Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM1
Choi, JY; Choi, Y; Hong, G; Kim, H; Lee, HW; Lee, K; Lee, KW; Mori, S; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T1
Su, QM; Ye, XG1
An, J; Chung, YH; Kim, GA; Kim, KM; Lee, D; Lee, HC; Lee, YS; Lim, YS; Shim, JH; Suh, DJ1
Chen, RC; Dai, XH; Fan, XG; Huang, Y; Huang, ZB; Li, N; Li, WT; Yi, PP; Zhang, BX; Zhao, SS; Zhou, RR1
Cholongitas, E; Papatheodoridis, G; Pipili, C1
Ahn, SH; Hahn, KY; Han, KH; Kim, BK; Kim, DY; Kim, HC; Kim, JK; Kim, SU; Park, JY; Park, YH; Shin, SH1
Anan, A; Irie, M; Iwata, K; Kawashima, M; Morihara, D; Sakisaka, S; Serrano-Luna, J; Shakado, S; Shibayama, M; Sohda, T; Takeyama, Y; Tanaka, T; Ueda, S; Yamauchi, E1
Arama, V; Bjork, S; Bludzin, W; Habersetzer, F; Jinga, M; Kamar, D; Klauck, I; Leblebicioglu, H; Lescrauwaet, B; Morais, E; Niederau, C; Simon, K; Ulusoy, S; Vermehren, J; Zarski, JP; Zeuzem, S1
Acurcio, Fde A; Almeida, AM; Andrade, EI; Brandão, CM; Cherchiglia, ML; Oliveira, GL; Silva, AL1
Chen, CY; Chien, RN; Chuang, WL; Hsieh, TY; Hu, CT; Hu, TH; Kao, JH; Lin, CC; Lin, HC; Peng, CY1
Chen, Z; Li, M; Liu, Z; Wu, J; Xu, G; Zhang, Q1
Calvaruso, V; Craxì, A1
Colombo, M; Della Corte, C; Triolo, M1
Esteban, R; Pérez-Cameo, C; Pons, M1
Cho, Y; Cho, YY; Choi, WM; Kim, YJ; Lee, DH; Lee, HS; Lee, JH; Lee, M; Lee, YB; Yoo, JJ; Yoon, JH; Yu, SJ1
Chan, HH; Chen, WC; Cheng, JS; Chiang, PH; Hsu, PI; Lai, KH; Lin, HS; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, HM; Yu, HC1
Choe, WH; Choi, YJ; Kim, JH; Ko, SY; Kwon, SY; Moon, HW1
Chung, RT; Fishman, JA; Wright, AJ1
Cai, SH; Jiang, YG; Lv, FF; Peng, J; Zhang, YH1
Chanson, P; Pariente, A1
Han, S; Heo, NY; Lee, HC; Lim, YS; Shim, JH; Suh, DJ1
Kang, Y; Lin, X; Liu, H; Lu, M; Mao, R; Qin, Y; Wang, J; Zhang, J; Zhang, Y; Zhu, H1
Chang, JY; Chen, CH; Chien, RN; Hu, TH; Hung, CH; Lee, CM; Lin, CL; Lu, SN; Tseng, PL; Wang, JH1
Cho, HC; Cho, JY; Choi, MS; Gwak, GY; Koh, KC; Lee, JH; Paik, SW; Paik, YH; Sohn, W; Yoo, BC1
Cho, JH; Choi, JY; Huh, S; Kang, YJ; Kim, CD; Kim, HK; Kim, JS; Kim, YL; Kwon, O; Lim, JH; Park, GY; Park, SH1
Doss, W; El Din, SS; Hassan, K; Maklad, S; Zeid, AA1
Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I1
Cai, HD; Gao, XH; Li, YQ; Lu, XZ; Ma, XY; Sun, AM; Xu, DZ; Yu, HY; Zhang, LY; Zhao, LF1
Hu, P; Shi, XF; Wang, ZY; Yang, CX; Zhang, DZ; Zhou, Z1
Shouval, D1
Hu, H; Hu, P; Liu, F; Ren, H; Wang, X; Wei, F; Zhang, D1
Jang, JY; Kim, BH; Kim, JW; Lee, CK; Shim, JJ1
Abe, H; Chayama, K; Chen, CL; Chen, DS; Hu, JT; Huang, YW; Kao, JH; Takahashi, S; Tsuge, M; Wang, TC; Yang, SS1
Flisiak, R; Jaroszewicz, J; Kowalczuk, O; Lapiński, TW; Nikliński, J; Parfieniuk-Kowerda, A; Trzos, A1
Błudzin, W; Dziambor, A; Goryszewski, D; Kolasa, K; Lescrauwaet, B; Postawa-Kłosińska, B; Sieklucki, J; Simon, K1
Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH2
Chen, G; Hu, XY; Luo, JX; Wang, YY; Yang, F; Zhang, Y; Zhong, S; Zhou, TY1
Cainelli, F; Comparcola, D; Della Corte, C; Nobili, V; Vento, S1
Kim, JH; Kim, KH; Park, ES; Park, YK1
Lei, Y; Liu, JY; Xu, H; Zeng, T; Zhong, S; Zhou, Z1
Chan, GC; Chan, TM; Choy, BY; Kwan, LP; Ma, MK; Mok, MM; Seto, WK; Tang, CS; Yap, DY; Yuen, MF; Yung, S1
Chen, L; Li, X; Liu, Y; Wang, Y; Xin, S; Xu, D; Zhang, XX; Zhao, P1
Baik, SK; Chae, HB; Hong, SP; Kim, CW; Kim, JH; Kim, MY; Kim, YS; Lee, CD; Lee, HJ; Lee, JI; Lee, JW; Lee, MS; Park, CK; Park, SH; Seo, YS; Suh, SJ; Um, SH; Yim, HJ1
Berg, T; van Bömmel, F1
Patel, K; Tillmann, HL1
Gerlich, WH1
Locarnini, S; Warner, N1
Beggel, B; Kaiser, R; Neumann-Fraune, M; Obermeier, M1
Chouta, A; Dalekos, GN; Drakoulis, C; Gogos, C; Hatzis, G; Ilias, A; Karamanolis, D; Ketikoglou, I; Manesis, E; Manolakopoulos, S; Mela, M; Mimidis, K; Nikolopoulou, G; Papatheodoridis, GV; Raptopoulou-Gigi, M; Touloumi, G; Vafiadis-Zouboulis, I1
Afdhal, NH; Bonder, A; Lau, D; Patwardhan, VR; Sengupta, N1
Hwang, JH; Jang, ES; Jeong, SH; Kim, JW; Kim, N; Lee, DH; Lee, SS; Min, BY; Park, YS; Seong, MH; Shin, CM; Sohn, HR; Song, JC1
Chen, X; Gao, W; Li, D; Peng, J; Wen, F; Xia, J; Xu, C; Xu, M; Yao, Z1
Alcantara, L; Burak, KW; Coffin, CS; Klein, P; Myers, RP; Pang, JX; Rezaeeaval, M1
Ahn, DG; Baek, EK; Cho, HJ; Chung, HW; Kim, HJ; Kwon, JC; Lee, H; Lee, JJ; Ze, E1
Ozdogan, OC; Yegin, EG1
Fan, H; Fan, Y; Ge, Y; Li, D; Liu, X; Liu, Z; Lyu, W; Yang, H; Zhou, B1
Abramson, JS; Chung, RT1
Cao, Y; Huang, H; Li, H; Li, X; Lin, S; Lin, T; Lin, Y; Liu, Q; Peng, J; Wang, W; Wu, X; Xu, B; Ye, S; Zhang, H; Zhu, J1
Chen, J; Chen, ZH; Dong, M; Li, X; Lin, Q; Lin, ZX; Ma, XK; Ruan, DY; Wang, TT; Wei, L; Wen, JY; Wu, DH; Wu, XY; Xing, YF; Zhong, X1
Borsa-Lebas, F; Cacoub, P; Carrat, F; Fillion, A; Lacombe, K; Lopes, A; Loustaud-Ratti, V; Miailhes, P; Piroth, L; Pol, S; Rosenthal, E; Salmon, D1
Geipel, A; Gerlich, WH; Glebe, D; Kaiser, R; Neumann-Fraune, M; Niekamp, H; Protzer, U; Seiz, PL; Zhang, K1
Andrade, JR; Barros, LM; Bertolini, DA; Carrilho, FJ; Conde, SR; de Araújo, LV; Ferreira, AC; Ferreira, AS; Galvan, J; Gomes-Gouvêa, MS; Kliemann, DA; Kunyoshi, AS; Leite, AG; Lyra, AC; Mendes-Corrêa, MC; Nastri, AC; Oikawa, MK; Piccoli, LZ; Pinho, JR; Rezende, RE; Soares, MC; Teixeira, R1
Jia, J; Wu, X; You, H1
Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS1
Hong, SP; Hwang, SG; Jang, ES; Jeong, SH; Kang, SK; Lee, JH; Park, SJ1
Ha, FS; Han, T; Liu, H; Liu, L; Nie, CY; Zhang, Q1
Caccuri, F; Caruso, A; Castelli, F; De Francesco, MA; Gargiulo, F; Giagulli, C; Spinetti, A; Zaltron, S1
Gao, H; Li, X; Lin, M; Lin, T; Pan, C; Wang, X; Zhou, R1
Ouyang, R; Ye, X1
Yuen, MF1
Ari, A; Avci, M; Bal, F; Biçer, KÇ; Genç, VE; Özsu Caymaz, S1
Ahn, SH; Choi, SH; Chon, YE; Han, KH; Hong, SP; Jin, B; Kim, DY; Kim, KH; Kim, ND; Kim, S; Nam, CM; Park, JH; Park, JY1
Chen, L; Huang, Y; Mao, R; Qi, X; Qin, Y; Wang, J; Zhang, J1
Bowden, S; Chang, TT; Chao, YC; de Man, RA; Gish, RG; Han, KH; Llamoso, C; Locarnini, S; Tang, H; Yu, M1
Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR1
Bang, SJ; Jeong, ID; Jung, SW; Kim, BG; Kim, CJ; Kim, EH; Kim, JH; Kim, MH; Lee, BU; Park, BR; Park, JH; Park, NH; Shin, JW; Sung, SJ1
Cui, X; Dai, J; Huang, M; Jiang, X; Li, J; Ning, H; Su, F; Yang, S1
Allegra, S; Boglione, L; D'Avolio, A; De Nicolò, A; Di Perri, G; Pensi, D; Simiele, M1
Liu, Y; Qiu, P; Wang, G; Wen, J; Wen, P; Xiao, X; Xu, L; Zhou, SF1
Chan, HH; Chang, HW; Chen, WC; Cheng, JS; Chiang, PH; Hsu, PI; Lai, KH; Tsai, WL; Tsay, FW; Yu, HC1
Cheong, JY; Cho, SW; Hwang, JA; Hwang, JC; Kim, KB; Kim, SS; Lim, SG; Yang, MJ1
Boettler, T; Thimme, R1
Cai, S; Jiang, Y; Lv, F; Peng, J; Yu, T; Zhang, Y1
Ahn, SH; Chong, Y; Kang, HS; Kim, BK; Kim, DH; Kim, KH; Lee, AR; Park, ES; Park, S; Park, YK; Rhee, JK; Shin, GC; Yang, SI1
Chen, JZ; Chen, SL; Du, XF; Hu, XQ; Shao, LY; Wang, J; Wang, JL; Weng, XH; Yu, YQ; Zhang, WH1
Akarca, US; Brouwer, WP; Guo, S; Hansen, BE; Janssen, HL; Simon, K; Sonneveld, MJ; Streinu-Cercel, A; Tabak, F; Xie, Q; Zeuzem, S; Zhang, N; Zhang, Q1
Demirhan, YE; Gultekin, G; Isal, B; Khodor, H; Ozaras, R; Unal, UK; Yetim, N1
Amani, A; Niederau, C; Thiel, A1
Hwang, SG; Jang, MK; Jeong, SH; Jung, YK; Kim, BH; Kim, HS; Kim, IH; Kim, JH; Kim, JW; Kim, SG; Kim, TY; Kim, YS; Lee, JI; Lee, JW; Lee, SH; Park, H; Park, JW; Park, SJ; Seo, YS; Suh, SJ; Yim, HJ1
Park, JG; Park, SY1
Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT1
Ahn, SH; Cho, M; Han, KH; Heo, J; Kim, CW; Kim, HH; Lee, HJ; Park, JY; Park, SY; Tak, WY; Um, SH; Woo, HY; Yoon, KT1
Hiramatsu, N; Takehara, T; Yamada, R1
Ao, Y; Chen, S; Chong, Y; Gao, Z; Huang, M; Jie, Y; Li, X; Lin, G; Shi, H; Wu, Y; Yang, F; Zhang, M1
Cai, B; Chen, J; Liao, Y; Lu, X; Su, Z; Tao, C; Wang, L; Ying, B; Zhang, Q1
Kittitrakul, C; Leowattana, W; Nontprasert, A; Phumratanaprapin, W; Poovorawan, K; Sriboonvorakul, N; Tangkijvanich, P; Thu, AM; Wilairatana, P1
Ahn, SH; Chon, YE; Han, KH; Jung, KS; Kang, W; Kim, BK; Kim, do Y; Kim, HS; Kim, SU; Park, JY1
Cai, XF; Guo, H; Hu, JL; Huang, AL; Long, QX; Luo, YY; Tao, Y; Zhang, WL1
Dai, M; Fan, Z; Huang, F; Jiang, Q; Lin, R; Liu, Q; Shang, J; Sun, J; Wang, H; Xu, N; Zhang, Y1
Bair, MJ; Chang, CW; Chen, CJ; Chen, MJ; Chu, CH; Hu, KC; Lee, KH; Lin, CC; Lin, SC; Liou, TC; Liu, CY; Shih, SC; Wang, HY; Wang, TE1
Fujioka, S; Ikeda, F; Kariyama, K; Kobashi, H; Miyatake, H; Morimoto, Y; Moriya, A; Okamoto, R; Seno, T; Takaguchi, K; Takaki, A; Takayama, H; Toshimori, J; Wada, N; Yabushita, K; Yamamoto, K; Yasunaka, T1
An, J; Choi, J; Chung, YH; Kim, KM; Kim, SO; Kim, SW; Lee, D; Lee, HC; Lee, YS; Lim, YS; Shim, JH; Suh, DJ1
Cao, Y; Dai, CY; Hou, W; Jiang, B; Li, XM; Lu, W; Su, R; Xu, J1
Anzai, K; Arase, Y; Hirose, S; Kagawa, T; Mine, T; Nagata, N; Shiraishi, K; Tsuruya, K1
Liu, Y; Qiu, P; Wang, GL; Wen, JB; Wen, P; Xiao, XZ; Xu, LF; Zhou, SF1
Song, J; Sun, M; Tan, G; Wang, J; Wu, X1
Chan, SH; Chang, TT; Cheng, PN; Huang, W; Lin, YJ; Su, IJ; Tsai, HW; Wu, HC; Wu, IC; Yen, CJ1
Aykın, N; Çevik, F; Demirtürk, N; Doğan, N; Koca, B; Köken, T1
Cheng, J; Liu, S; Wang, Q; Wang, X; Xing, H; Yang, S1
Li, YH; Wu, HM; Xu, Y; Yang, J; Yang, JH; Yang, LH; Yue-Meng, W1
Casarin, P; Castelnovo, L; Dal Maso, L; Gattei, V; Mauro, E; Mazzaro, C; Monti, G; Pozzato, G; Urraro, T; Zignego, AL1
Chen, FY; Cheng, Z; Huang, HH; Shi, KQ; Zhang, MY; Zheng, JN; Zheng, MH; Zhu, GQ; Zou, ZL1
Ahn, H; An, H; Choe, WH; Jung, YK; Kim, JH; Kim, SG; Kim, SU; Kim, TY; Kim, YS; Lee, JH; Seo, YS; Suh, SJ; Suk, KT; Um, SH; Yim, HJ; Yim, SY1
Atay, K; Canbakan, B; Durcan, E; Gültepe, İ; Hatemi, İ; Köroğlu, E; Özdemir, S; Sonsuz, A; Tuncer, M; Yurttaş, B1
Defresne, F; Sokal, E1
Gao, Y; Ke, W; Liu, L; Yang, Y; Yao, Z; Ye, X; Zhang, C; Zhou, S1
Choi, MS; Gwak, GY; Kim, H; Kim, JH; Kim, K; Koh, KC; Lee, JH; Paik, SW; Paik, YH; Sinn, DH1
Hiraoka, A; Kumada, T; Tada, T; Tanaka, J; Toyoda, H; Tsuji, K1
Ahn, SH; Baatarkhuu, O; Han, KH; Kim, BK; Kim, DY; Kim, HS; Kim, SU; Kim, YJ; Park, JW; Park, JY; Song, KJ1
Bao, R; Bao, S; Chen, R; Guo, Q; Liu, K; Liu, Y; Wang, H; Xiang, X; Xie, J; Xie, Q1
Akyildiz, M; Balci, D; Cinar, K; Dayangac, M; Gungor, G; Hazinedaroglu, S; Idilman, R; Kalkan, C; Keskin, O; Tokat, Y; Yilmaz, TU1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Fouzas, I; Giakoustidis, D; Giouleme, O; Goulis, I; Imvrios, G; Papanikolaou, V; Vasiliadis, T1
Chang, CY; Chen, TB; Hsu, YC; Lin, JT; Mo, LR; Tseng, CM1
Luis, AP; Luo, H; Pan, M; Shuai, P; Xiong, Z; Yu, S; Zhang, Z1
Jia, J; Kong, Y; Wei, W; Wu, X; You, H; Zhou, J1
Chen, Y; Cheng, KL; Duan, XW; Duan, ZP; Li, Y; Qiu, Q; Wang, L; Xu, MM; Yang, LK1
Brahmania, M; Brouwer, WP; Feld, J; Hansen, T; Janssen, HL; Kowgier, M; Mazzulli, T; Wong, D1
Ahn, SH; Cho, EY; Hwang, SG; Jeong, SH; Jung, YK; Kim, HS; Kim, IH; Kim, JH; Kim, JW; Lee, JI; Lee, JM; Lee, JW; Lee, SH; Park, SJ; Seo, YS; Suh, SJ; Yim, HJ1
Chao, J; Huo, M; Liu, P; Zhang, H1
Cho, YK; Choi, KY; Jeon, WK; Jung, YS; Kim, BI; Kim, HJ; Park, DI; Park, JH; Park, SK; Sohn, CI; Yang, HJ1
Gao, F; Geng, M; Jiang, Y; Li, A; Li, X; Li, Y; Liu, H; Liu, Y; Sun, L; Wang, R; Wang, X; Yang, Z; Ye, X; Zeng, H; Zhang, H; Zhou, G1
Ahn, SH; Baatarkhuu, O; Han, K; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Ku, HJ; Lee, S; Park, JY1
Kim, HY1
Asano, M; Dohi, T; Enomoto, N; Gatanaga, H; Honda, M; Inoue, T; Kaneko, S; Kawamura, YI; Matsumoto, A; Mizokami, M; Murata, K; Nishida, N; Oka, S; Sakamoto, M; Shirasaki, T; Shuno, Y; Sugiyama, M; Tanaka, E; Yano, H1
Hu, J; Ji, D; Li, X; Liao, H; Liu, Y; Wu, J; Xin, S; Xu, D; You, S; Zhang, XX; Zhao, J1
Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Lin, ZY; Yeh, ML; Yu, ML1
Babudieri, S; Garrucciu, G; Madeddu, G; Maida, I; Melis, M; Mura, MS; Muredda, AA; Ortu, S1
Huang, KW; Kuan, YC; Luo, JC; Tam, KW1
Dixit, VK; Jain, AK; Nath, G; Singh, N; Srivastava, M1
Arcaini, L; Gotti, M; Merli, M; Rattotti, S1
Hong, LJ; Wei, L; Ying, H; Zhang, J1
Lim, YS1
Li, B; Li, XL; Qi, W; Wang, CX; Wei, SF; Wu, LY; Zhang, YD; Zhang, YR; Zhou, N1
Chen, FY; Cheng, Z; Huang, HH; Shi, KQ; Van Poucke, S; Zhang, MY; Zheng, JN; Zheng, MH; Zhu, GQ1
Buzzetti, E; Davidson, BR; Gurusamy, KS; Mantzoukis, K; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E1
Capobianchi, MR; D'Offizi, G; Menzo, S; Piselli, P; Solmone, M; Vincenti, D1
Ahn, SH; Chon, YE; Han, KH; Jung, KS; Kim, BK; Kim, DY; Kim, SU; Myoung, SM; Park, JY1
He, L; Jiang, Y; Liu, X; Wang, X; Yang, Z; Zhang, S; Zhao, Y1
Deng, J; Li, T; Li, Y; Su, MZ; Wang, QY; Wang, S; Xiang, KH; Xu, XZ; Zhao, CY; Zhuang, H1
Hu, C; Huang, H; Li, Y; Liu, J; Yang, D; Yuan, G; Zhang, YY; Zhou, F; Zhou, Y1
Ahn, JS; Jeon, HJ; Jung, SW; Kim, HR; Lee, JH; Noh, JH; Park, NH; Shin, JW; Yang, Y1
Chen, CY; Hsu, YC; Lee, TY; Lia, HC; Yang, SS1
Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G1
Lee, JH; Lee, YB1
Byun, KS; Heo, J; Kim, BH; Kim, D; Kim, DJ; Kim, TH; Kweon, YO; Lee, HJ; Lee, KS; Lee, MS; Lee, YS; Lim, YS; Paik, SW; Suh, DJ; Um, SH; Yu, K1
Chang, CS; Lee, SW; Lee, TY; Li, YC; Liao, YJ; Wu, CY; Yang, SS; Yeh, HZ1
Chun, JM; Han, YS; Hur, K; Jang, SY; Kang, MK; Kweon, YO; Lee, HJ; Lee, HW; Lee, YR; Park, JG; Park, SY; Tak, WY1
Han, Z; Huang, M; Liu, J; Shi, H; Xia, J; Xue, J; Zhang, S; Zhu, Z1
Choi, J; Lim, YS1
Lee, JH; Nam, JY1
Ahn, SH; Hur, SS; Kang, HS; Kim, DH; Kim, KH; Kwon, SY; Lee, AR; Lee, JH; Park, ES; Park, S; Park, YK; Sim, S1
Arai, M; Fujiwara, K; Haga, Y; Kanda, T; Kato, N; Nakamura, M; Oda, S; Yasui, S; Yokosuka, O; Yonemitsu, Y1
Hagiwara, S; Ida, H; Komeda, Y; Kudo, M; Nishida, N; Nishijima, N; Osaki, Y; Sakurai, T; Takita, M; Ueshima, K; Watanabe, T1
Chang, JY; Choe, BH; Choe, JY; Jeong, IS; Kim, JW; Kim, JY; Kim, KM; Ko, JS; Lee, KJ; Moon, JS; Yang, HR1
Padma, UD; Surendran, S; Udayakumar, VP1
Chen, Q; Liu, W; Liu, YT; Wang, FL; Zhu, GY1
Li, W; Li, Y; Liu, Y; Wang, L; Yu, S1
Chen, D; Guo, X; Li, Q; Liu, K; Ouyang, Y; Wang, Y; Wei, F; Wu, J; Zhang, Y1
Chen, YM; Deng, H; Gao, ZL; Lin, CS; Mei, YY; Peng, L; Xie, C; Xie, DY; Xu, WX; Zhang, Q; Zhao, ZX; Zhu, X1
Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A1
Caviglia, GP; Ngatchou, D; Olivero, A; Saracco, GM; Smedile, A1
Balkan, A; Gülşen, MT; Karaoğlan, İ; Namıduru, M; Şahin, A1
Li, YH; Wan, YM; Wu, HM; Wu, XN; Xu, Y; Xu, ZY1
Bair, MJ; Chen, CJ; Chen, MJ; Chu, CH; Lin, CC; Lin, ZY; Liu, CY; Shih, SC; Wang, HY; Wang, TE1
Ahn, SH; Bae, SH; Cheong, JY; Han, KH; Jang, BK; Jeong, SW; Kim, BI; Kim, DJ; Kim, JK; Kim, MY; Kim, SG; Kim, TY; Kwon, JH; Kwon, SY; Lee, HW; Lee, JW; Myoung, S; Park, JY; Seo, YS; Tak, WY; Yim, HJ; Yoon, KT1
Li, T; Lin, C; Qu, Y; Wang, L; Wang, Y; Yang, B1
Akita, T; Kumada, T; Kurisu, A; Miyake, N; Ohisa, M; Tada, T; Tanaka, J; Toyoda, H; Yasuda, S1
Ji, J; Jia, Y; Shen, Y; Xun, P; Zhou, J1
Chan, TM; Choy, BY; Fung, JYY; Ma, MKM; Seto, WK; Tang, C; Yap, DYH1
Kimura, A; Mizokami, M; Murata, K; Noguchi, M; Sugiyama, M; Suizu, F; Tsukuda, S; Watashi, K1
Aizaki, H; Fukano, K; Muramatsu, M; Nakajima, S; Toyoda, T; Tsukuda, S; Wakae, K; Wakita, T; Watashi, K1
Buzo, BF; de Seixas Santos Nastri, AC; Marques Rossetti, RA; Mendrone-Júnior, A; Ramos, JF; Rocha, V; Salles, N1
Babudieri, S; Bagella, P; Bandiera, F; Calvisi, DF; Fiore, V; Garrucciu, G; Madeddu, G; Mannu, F; Melis, M; Muredda, AA; Ortu, S; Zaru, S1
Kogure, T; Niizuma, K; Ogawa, Y; Tominaga, T1
Ahn, SH; Baek, YH; Chang, Y; Choe, WH; Jang, JW; Jang, JY; Kim, GA; Kim, HY; Kim, JH; Kim, M; Kim, MA; Kim, SG; Kim, SU; Kim, YJ; Kim, YS; Koh, M; Kwon, JH; Lee, HA; Lee, HW; Lee, JH; Lee, SW; Lee, YS; Lim, YS; Park, Y; Seo, YS; Shim, JJ; Sinn, DH; Yang, H; Yim, HJ; Yoon, JH; Zoulim, F1
Ahn, SH; Cho, ES; Dezhbord, M; Kim, DH; Kim, KH; Koo, JE; Lee, AR; Lee, HC; Lee, JH; Park, ES; Park, S; Park, YK1
Ke, Z; Li, X; Lian, D; Pan, Y; Yuan, J1
Ahn, SH; Bae, SH; Heo, J; Jang, JY; Kim, CW; Kim, DJ; Kim, IH; Park, JY; Tak, WY; Woo, HY1
Choi, YM; Kim, BJ; Kim, H; Lee, SA; Lee, SY1
Jang, BK1
Wang, L; Xie, B; Xu, L; Ye, Z; Zheng, Q1
Gu, X; Guan, M; Li, X; Qiu, J; Zhang, Y; Zhou, Q; Zou, Y1
Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A; Yoshida, K1
Chen, R; Li, L; Li, X; Li, Y; Liao, H; Liu, W; Liu, Y; Si, L; Wang, J; Xu, D; Yao, Z; Zhao, J1
Bansal, S; Daniel, JF; Kansu, A; Kelly, D; Martin, C; Mieli-Vergani, G; Tizzard, S; Vergani, D; Wirth, S; Zhou, J1
Chen, J; Fan, Y; Qi, J; Shen, Y; Wang, Y; Wu, D; Xu, Y1
Bhan, AK; Chung, RT; Ghany, MG; Hinerman, AS; Jain, MK; Khalili, M; King, WC; Kleiner, DE; Lisker-Melman, M; Sterling, RK; Sulkowski, M; Wahed, AS; Wong, DK1
de Carvalho Santana, R; de Lourdes Candolo Martinelli, A; Dessordi, R; Guimarães, MP; Navarro, AM; Romão, EA; Watanabe, LM1
Bai, L; Ise, RM; Liu, H; Ran, J; Shang, J; Tang, H; Tu, Y; Zhou, J1
Chen, Y; Huang, H; Lai, X; Lan, J; Lu, Y; Luo, Y; Ni, L; Shi, J; Si, T; Tan, Y; Wu, Y; Ye, B; Yu, J; Zhao, Y; Zhu, P1
Fan, J; Jing, J; Li, M; Liu, N; Xiong, X; Ye, W; Zhong, H; Zong, Z1

Reviews

119 review(s) available for lamivudine and guanine

ArticleYear
Experience with lamivudine against hepatitis B virus.
    Intervirology, 1997, Volume: 40, Issue:5-6

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Reverse Transcriptase Inhibitors

1997
Antiviral agents for non-human immunodeficiency virus infections.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir

1999
Nucleoside analogues for chronic hepatitis B.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:12

    Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Ganciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors

2001
[New management strategies for hepatitis B].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:2

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Lamivudine; Organophosphonates

2002
Prevention of recurrent hepatitis B post-liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Viral Hepatitis Vaccines

2002
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:3

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Postoperative Complications; Recurrence; Time Factors; Transplantation Immunology

2003
[Antiviral therapy for chronic viral hepatitis B and C].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2003
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
    Antiviral research, 2003, Volume: 60, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infectious Disease Transmission, Professional-to-Patient; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Physicians; Risk Factors; Risk Management; Tenofovir; Viral Load

2003
Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.
    The AIDS reader, 2004, Volume: 14, Issue:3

    Topics: Adenine; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir

2004
[New approaches in the treatment of hepatitis B].
    Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21

    Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine

2004
Molecular virology of hepatitis B virus.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Transcription, Genetic; Viral Proteins; Virus Replication

2004
New treatment of chronic hepatitis B.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Adenine; Animals; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Organophosphorus Compounds; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2004
[Advances in the treatment of acute hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Acute Disease; Anticoagulants; Antiviral Agents; Carrier State; Clinical Trials as Topic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Interferons; Lamivudine

2004
[Recent advances in the treatment of fulminant hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug

2004
[Treatment and selection criteria for chronic hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Mutation; Patient Selection

2004
A review of entecavir in the treatment of chronic hepatitis B infection.
    Current medical research and opinion, 2005, Volume: 21, Issue:11

    Topics: Animals; Clinical Trials as Topic; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome

2005
[Treatment of chronic hepatitis B].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 2

    Topics: Adenine; Administration, Oral; Antiviral Agents; Biopsy; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Drug Tolerance; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver; Mutation; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication

2006
[Liver transplantation for complications of hepatitis B].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 2

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Vaccination; Viral Load; Virus Replication

2006
Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.
    Minerva gastroenterologica e dietologica, 2006, Volume: 52, Issue:1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins

2006
Personal view: the management of chronic hepatitis B infection.
    Alimentary pharmacology & therapeutics, 2006, Apr-01, Volume: 23, Issue:7

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates; Tenofovir

2006
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
    Annals of clinical microbiology and antimicrobials, 2006, Apr-06, Volume: 5

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir

2006
[Entecavir--close perspective for using it].
    Przeglad epidemiologiczny, 2006, Volume: 60, Issue:1

    Topics: Animals; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine

2006
Hepatitis B: the pathway to recovery through treatment.
    Gastroenterology clinics of North America, 2006, Volume: 35, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors

2006
New developments in the treatment of chronic hepatitis B.
    Expert opinion on biological therapy, 2006, Volume: 6, Issue:9

    Topics: Adenine; Animals; Antiviral Agents; Clinical Trials as Topic; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Patient Selection; Polyethylene Glycols; Recombinant Proteins

2006
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-01, Volume: 43, Issue:7

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Preventive Medicine; Tenofovir

2006
[Therapy of hepatitis B virus infection].
    Praxis, 2006, Sep-06, Volume: 95, Issue:36

    Topics: Adenine; Antiviral Agents; Drug Antagonism; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Forecasting; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates; Polyethylene Glycols; Prognosis; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors

2006
[Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10 Pt 2

    Topics: Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome

2006
Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.
    Pharmacotherapy, 2006, Volume: 26, Issue:12

    Topics: Animals; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine

2006
Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.
    Clinical drug investigation, 2007, Volume: 27, Issue:1

    Topics: Adenine; Administration, Oral; Algorithms; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Randomized Controlled Trials as Topic; Treatment Outcome

2007
New and emerging treatment of chronic hepatitis B.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:3

    Topics: Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Forecasting; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome

2007
Improving outcomes for patients with chronic hepatitis B.
    Current gastroenterology reports, 2007, Volume: 9, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Telbivudine; Thymidine; Treatment Outcome; Viral Load

2007
[Drugs for hepatitis B and C infection].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Mutation; Oligopeptides; Organophosphonates; Proline; Ribavirin; Serine Proteinase Inhibitors

2007
[Mechanisms of drug resistance in hepatitis viruses B and C].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferons; Lamivudine; Mutation; Organophosphonates; Ribavirin; Viral Nonstructural Proteins

2007
[Entecavir: a new hope for the treatment of chronic hepatitis B].
    Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:5

    Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Viremia

2007
Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.
    Expert opinion on investigational drugs, 2007, Volume: 16, Issue:6

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Thymidine

2007
Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.
    Journal of gastroenterology, 2007, Volume: 42, Issue:5

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Organophosphonates

2007
Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Antiviral Agents; China; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic

2007
Treatment of chronic hepatitis B in HIV-infected patients in 2007.
    Journal of HIV therapy, 2007, Volume: 12, Issue:1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2007
Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
    Reviews in gastroenterological disorders, 2007,Spring, Volume: 7, Issue:2

    Topics: Adenine; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Organophosphonates

2007
[Indications for antiviral therapy for chronic hepatitis B].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:10

    Topics: Adenine; Antiviral Agents; Biomarkers; Carrier State; Consensus Development Conferences as Topic; DNA, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Japan; Lamivudine; Organophosphonates; Societies, Medical

2007
[Natural course and recommendation of therapy for HBV infection].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:10

    Topics: Antiviral Agents; Biomarkers; Carrier State; DNA, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Risk Factors

2007
[Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:10

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates

2007
[Attention-getting sexually transmitted diseases: Hepatitis B].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Adenine; Adenosine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral

2007
Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.
    Alimentary pharmacology & therapeutics, 2007, Volume: 26 Suppl 2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Nucleotides; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Virus Replication

2007
[Pharmacological agents for the treatment of chronic hepatitis B].
    Gastroenterologia y hepatologia, 2008, Volume: 31, Issue:3

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Time Factors; Treatment Outcome

2008
[Anti-viral therapy of type B chronic hepatitis. 1. Selection of evidence-based therapeutic policy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Jan-10, Volume: 97, Issue:1

    Topics: Antiviral Agents; Evidence-Based Medicine; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Middle Aged

2008
Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.
    Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:12

    Topics: Adenine; Antiviral Agents; Cost-Benefit Analysis; Epidemiologic Methods; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates

2008
Review article: current antiviral therapy of chronic hepatitis B.
    Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:2

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication

2008
[Treatment recommendations of chronic hepatitis B. Did the world escape us?].
    Przeglad epidemiologiczny, 2008, Volume: 62, Issue:1

    Topics: Adenine; Antiviral Agents; Disease Management; Drug Therapy, Combination; Guanine; Health Planning Guidelines; Health Services Accessibility; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; National Health Programs; Organophosphonates; Poland; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Treatment Outcome

2008
Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
    Scandinavian journal of infectious diseases, 2008, Volume: 40, Issue:6-7

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Sweden; Tenofovir

2008
[Management of chronic hepatitis B in treatment-naive patients].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 51, Issue:6

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Korea; Lamivudine; Organophosphonates; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins

2008
[Management of antiviral-resistant chronic hepatitis B virus infection].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 51, Issue:6

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Multiple, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome

2008
Hepatitis B and liver transplantation: 2008 update.
    Reviews in medical virology, 2009, Volume: 19, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2009
[Interferon in hepatitis B].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Multicenter Studies as Topic; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Randomized Controlled Trials as Topic; Recombinant Proteins; Telbivudine; Thymidine; Treatment Outcome

2008
[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Multicenter Studies as Topic; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Replication

2008
[Entecavir].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Virus Replication

2008
[Resistance in hepatitis B virus].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Antiviral Agents; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Gene Products, pol; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Models, Molecular; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Virus Replication

2008
[Clinical management of patients with chronic hepatitis B virus infection].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Antiviral Agents; Biopsy; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Liver Transplantation; Male; Nucleosides; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication

2008
[Hepatitis B in patients with HIV infection].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication

2008
Role of combination therapy in chronic hepatitis B.
    Current gastroenterology reports, 2009, Volume: 11, Issue:1

    Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates; Salvage Therapy; Treatment Outcome

2009
Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Adenine; Adenine Nucleotides; Alanine Transaminase; Carcinoma, Hepatocellular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Treatment Outcome; Virus Replication

2008
Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Polyethylene Glycols; Practice Guidelines as Topic; Pyrimidinones; Randomized Controlled Trials as Topic; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2008
HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.
    Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29 Suppl 1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Virus Replication

2009
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Mutation; Recurrence; Time Factors; Treatment Outcome

2009
Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
    Current opinion in organ transplantation, 2009, Volume: 14, Issue:3

    Topics: Adenine; Administration, Oral; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Guanine; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome

2009
[Chronic hepatitis B: current therapy].
    Bulletin de l'Academie nationale de medecine, 2008, Volume: 192, Issue:8

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunotherapy, Active; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir; Treatment Outcome

2008
Current status of nucleoside antivirals in chronic hepatitis B.
    Drugs of today (Barcelona, Spain : 1998), 2009, Volume: 45, Issue:10

    Topics: Antiviral Agents; Cost-Benefit Analysis; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Pyrimidinones; Telbivudine; Thymidine

2009
Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:5

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2010
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
    World journal of gastroenterology, 2010, May-28, Volume: 16, Issue:20

    Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir

2010
On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adenine; Antiviral Agents; Asia; Biomarkers; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load; Virus Replication

2010
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
    Gastroenterology, 2010, Volume: 139, Issue:4

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Tenofovir

2010
Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2010, Volume: 13, Issue:8

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Nucleotides; Organophosphonates; Tenofovir; Treatment Outcome; Viral Load

2010
Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2011
Hepatitis B virus resistance to antiviral drugs: where are we going?
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Adenine; Antiviral Agents; Capsid; Clinical Protocols; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Virus Internalization; Virus Replication

2011
The impact of human immunodeficiency virus on viral hepatitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2011
[Treatment of patients with lamivudine-resistant chronic hepatitis B].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates

2011
[Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:2

    Topics: Adult; Antiviral Agents; Drug Administration Schedule; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male

2011
[Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B].
    Orvosi hetilap, 2011, May-29, Volume: 152, Issue:22

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Nucleotides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2011
[Progress and perspectives in treatment of chronic hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:4

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates

2011
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
    Antiviral therapy, 2011, Volume: 16, Issue:5

    Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2011
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.
    Virology journal, 2011, Aug-08, Volume: 8

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Organophosphonates; Salvage Therapy; Time Factors; Treatment Outcome; Viral Load

2011
Antiviral drugs for viruses other than human immunodeficiency virus.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir

2011
[The past, present and future treatment for chronic hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4

    Topics: Adenine; Adult; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates; Practice Guidelines as Topic

2011
[Interferon therapy for chronic hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4

    Topics: Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins

2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Interferons; Lamivudine; Liver Failure, Acute; Organophosphonates; Tenofovir

2012
[Pharmacological treatment of acute hepatitis B].
    Medicina clinica, 2012, May-19, Volume: 138, Issue:14

    Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2012
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
    Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:6

    Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load

2012
Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review.
    Die Pharmazie, 2012, Volume: 67, Issue:11

    Topics: Alanine Transaminase; Antiviral Agents; Data Interpretation, Statistical; DNA, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Randomized Controlled Trials as Topic; Treatment Outcome

2012
Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.
    Expert review of gastroenterology & hepatology, 2012, Volume: 6, Issue:6

    Topics: Adenine; Age Factors; Antiviral Agents; Comorbidity; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Life Style; Organophosphonates; Severity of Illness Index; Telbivudine; Tenofovir; Thymidine; Time Factors

2012
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.
    World journal of gastroenterology, 2012, Dec-28, Volume: 18, Issue:48

    Topics: Adenine; Antiviral Agents; Drug Resistance, Multiple; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Nucleotides; Organophosphonates; Prognosis; Tenofovir; Viral Load

2012
[Interdisciplinary aspects of and new drugs for chronic hepatitis B].
    Orvosi hetilap, 2013, Jul-21, Volume: 154, Issue:29

    Topics: Adenine; Antiviral Agents; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Gastroenterology; Guanine; Hematology; Hepatitis B, Chronic; Humans; Hungary; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Interdisciplinary Communication; Interferons; Lamivudine; Medical Oncology; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Rheumatology; Tenofovir

2013
[Reactivation of chronic hepatitis B].
    Vnitrni lekarstvi, 2013, Volume: 59, Issue:7

    Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Biomarkers; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Lamivudine; Organophosphonates; Rituximab; Tenofovir; Virus Activation

2013
Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:2

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; Creatinine; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Treatment Outcome

2014
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    World journal of gastroenterology, 2013, Oct-21, Volume: 19, Issue:39

    Topics: Adult; Aged; Antiviral Agents; Bilirubin; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Odds Ratio; Prothrombin Time; Serum Albumin; Serum Albumin, Human; Treatment Outcome; Viral Load

2013
Comparison of the efficacy of Lamivudine plus adefovir versus entecavir in the treatment of Lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.
    Clinical therapeutics, 2013, Volume: 35, Issue:12

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Treatment Outcome

2013
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
    Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Renal Insufficiency, Chronic; Telbivudine; Tenofovir; Thymidine

2014
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1

    Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine

2014
HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1

    Topics: Adenine; Age Factors; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Polyethylene Glycols; Precision Medicine; Recombinant Proteins; Sex Factors; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2014
Impact of HBV therapy on the incidence of hepatocellular carcinoma.
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Tenofovir

2014
New therapeutic perspectives in HBV: when to stop NAs.
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1

    Topics: Adenine; Algorithms; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine

2014
Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis.
    Virology journal, 2014, Mar-28, Volume: 11

    Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Organophosphonates; Treatment Outcome

2014
Management of chronic hepatitis B in children: an unresolved issue.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:5

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Carrier State; Child; Databases, Bibliographic; Guanine; Hepatitis B, Chronic; Humans; Immune Tolerance; Incidence; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Risk; Tenofovir

2014
Molecular diagnosis and treatment of drug-resistant hepatitis B virus.
    World journal of gastroenterology, 2014, May-21, Volume: 20, Issue:19

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Molecular Diagnostic Techniques; Mutation; Nucleic Acid Hybridization; Organophosphonates; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Tenofovir; Treatment Outcome

2014
Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:9

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Treatment Outcome

2014
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.
    Hepatology international, 2015, Volume: 9, Issue:3

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis

2015
Monotherapy for hepatitis B infection: a review of treatment options.
    Expert review of anti-infective therapy, 2015, Volume: 13, Issue:12

    Topics: Adenine; Animals; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Neoplasms; Organophosphonates; Telbivudine; Thymidine; Treatment Outcome

2015
The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:3

    Topics: Adult; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Incidence; Interferons; Lamivudine; Liver Neoplasms; Male; Middle Aged; Nucleosides; Nucleotides; Randomized Controlled Trials as Topic; Risk Factors

2016
Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Controlled Clinical Trials as Topic; Guanine; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Lamivudine; Organophosphonates; Telbivudine; Thymidine; Virus Activation

2016
Chronic hepatitis B in children: Therapeutic challenges and perspectives.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:2

    Topics: Adenine; Alanine Transaminase; Antigens, Viral; Antiviral Agents; Child; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Interferon-alpha; Lamivudine; Molecular Targeted Therapy; Organophosphonates; Practice Guidelines as Topic; Seroconversion; Telbivudine; Tenofovir; Thymidine; Viral Envelope Proteins

2017
Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.
    International journal of clinical pharmacy, 2016, Volume: 38, Issue:5

    Topics: Antineoplastic Agents; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Treatment Outcome

2016
A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B.
    International journal of environmental research and public health, 2016, 07-21, Volume: 13, Issue:5

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Odds Ratio; Organophosphonates; Treatment Outcome

2016
Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
    Journal of clinical gastroenterology, 2017, Volume: 51, Issue:6

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Randomized Controlled Trials as Topic

2017
Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:4

    Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation

2017
Management of Antiviral Resistance in Chronic Hepatitis B.
    Gut and liver, 2017, Mar-15, Volume: 11, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Tenofovir

2017
Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.
    Expert review of anti-infective therapy, 2017, Volume: 15, Issue:5

    Topics: Adenine; Antiviral Agents; Controlled Clinical Trials as Topic; Guanine; Hematologic Neoplasms; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Lamivudine; Organophosphonates; Survival Analysis; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Activation

2017
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    The Cochrane database of systematic reviews, 2017, Mar-21, Volume: 3

    Topics: Acute Disease; Antiviral Agents; Disease Progression; Guanine; Hepatic Encephalopathy; Hepatitis B; Hepatitis C, Chronic; Humans; Immunization, Passive; Interferons; Lamivudine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2017
Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Disease markers, 2017, Volume: 2017

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Organophosphonates; Retrospective Studies; Survival Analysis; Telbivudine; Tenofovir; Thymidine

2017
Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs.
    Clinical drug investigation, 2019, Volume: 39, Issue:9

    Topics: Adenine; Antiviral Agents; Bayes Theorem; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Network Meta-Analysis; Organophosphonates; Prospective Studies; Telbivudine; Tenofovir

2019
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
    International journal of molecular sciences, 2021, Feb-01, Volume: 22, Issue:3

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Randomized Controlled Trials as Topic; Reproducibility of Results; Tenofovir; Treatment Outcome; Viral Load

2021

Trials

81 trial(s) available for lamivudine and guanine

ArticleYear
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
    Gastroenterology, 2002, Volume: 123, Issue:6

    Topics: Adolescent; Adult; Alanine Transaminase; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2002
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.
    Gastroenterology, 2005, Volume: 129, Issue:4

    Topics: Adult; Antigens, Viral; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Ethnicity; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged

2005
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
    The New England journal of medicine, 2006, Mar-09, Volume: 354, Issue:10

    Topics: Adult; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Molecular Sequence Data; Treatment Outcome

2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
    The New England journal of medicine, 2006, Mar-09, Volume: 354, Issue:10

    Topics: Adult; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Middle Aged; Molecular Sequence Data; Treatment Outcome

2006
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.
    Gastroenterology, 2006, Volume: 130, Issue:7

    Topics: Adolescent; Adult; Aged; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load

2006
Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Treatment Outcome

2006
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Antiviral Agents; Cells, Cultured; DNA-Directed DNA Polymerase; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Plasmids; Treatment Outcome; Virus Replication

2007
[Investigation of entecavir medication of chronic hepatitis B patients in the Chongqing area who failed lamivudine treatment].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:1

    Topics: Adult; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Treatment Failure; Virus Replication; Young Adult

2007
One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
    Antiviral therapy, 2006, Volume: 11, Issue:7

    Topics: Adult; Antiviral Agents; China; DNA, Circular; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome

2006
[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].
    Zhonghua nei ke za zhi, 2006, Volume: 45, Issue:11

    Topics: Adolescent; Adult; Antiviral Agents; Double-Blind Method; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Viral Load

2006
[Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2007, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Evaluation; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Failure; Young Adult

2007
A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B.
    World journal of gastroenterology, 2007, Aug-21, Volume: 13, Issue:31

    Topics: Adult; Aged; Antiviral Agents; Disease Progression; DNA, Viral; Dose-Response Relationship, Drug; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Virus Replication

2007
The high incidence of the emergence of entecavir-resistant mutants among patients infected with lamivudine-resistant hepatitis B virus.
    The Tohoku journal of experimental medicine, 2007, Volume: 213, Issue:2

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors

2007
Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.
    PharmacoEconomics, 2007, Volume: 25, Issue:11

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Disease Progression; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Markov Chains; Organophosphonates; Quality of Life; Salvage Therapy

2007
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine

2007
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1

    Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Gene Dosage; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Retreatment; Treatment Outcome; Viral Load

2008
Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:9

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Time Factors; Treatment Failure; Viral Load; Young Adult

2008
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:11

    Topics: Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome

2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
    AIDS (London, England), 2008, Sep-12, Volume: 22, Issue:14

    Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Linear Models; Male; Middle Aged; Single-Blind Method; Virus Replication

2008
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
    Journal of hepatology, 2009, Volume: 50, Issue:2

    Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Recurrence; Viral Load

2009
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Mutation; Recurrence; Time Factors; Treatment Outcome

2009
[A study on the treatment of chronic hepatitis B with YMDD mutation].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:3

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Young Adult

2009
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
    Journal of viral hepatitis, 2009, Volume: 16, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Time Factors; Treatment Outcome

2009
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.
    Journal of gastroenterology, 2009, Volume: 44, Issue:8

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA

2009
[Five years trial of entecavir for chronic hepatitis B patients failed with lamivudine therapy in the Chongqing area].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:5

    Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Time Factors; Treatment Outcome; Virus Replication; Young Adult

2009
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
    Journal of viral hepatitis, 2010, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Viral Load; Young Adult

2010
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Treatment Outcome

2009
Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.
    Antiviral therapy, 2009, Volume: 14, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Salvage Therapy; Treatment Outcome; Young Adult

2009
The role of entecavir in preventing hepatitis B recurrence after liver transplantation.
    Journal of digestive diseases, 2009, Volume: 10, Issue:4

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention

2009
[Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:11

    Topics: Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Treatment Outcome; Young Adult

2009
[Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:12

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Time Factors; Treatment Outcome; Viral Load; Young Adult

2009
Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease.
    Hepatology (Baltimore, Md.), 2010, Volume: 51, Issue:3

    Topics: Adult; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Young Adult

2010
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
    Journal of hepatology, 2010, Volume: 52, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Virus Replication

2010
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.
    Antiviral therapy, 2010, Volume: 15, Issue:2

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome

2010
Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:8

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome

2010
Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients.
    Journal of viral hepatitis, 2010, Volume: 17 Suppl 1

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Asian People; China; DNA, Viral; Double-Blind Method; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome; Viral Load; Young Adult

2010
[Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:6

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lung Neoplasms; Lymphoma; Male; Middle Aged; Nucleosides; Pyrimidinones; Retrospective Studies; Telbivudine; Thymidine; Virus Activation

2010
Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
    Journal of medical virology, 2010, Volume: 82, Issue:11

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Young Adult

2010
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Chemoprevention; China; Female; Guanine; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Treatment Outcome; Virus Activation; Young Adult

2011
[Treatment efficacy of clevudine, entecavir and lamivudine in treatment-naive patients with HBeAg-positive chronic hepatitis B].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 56, Issue:6

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2010
[Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2010, Volume: 24, Issue:5

    Topics: Adult; Antiviral Agents; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Nucleosides; Pyrimidinones; Telbivudine; Thymidine; Viral Load

2010
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 Years.
    Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:4

    Topics: Adult; Alanine Transaminase; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome; Viral Load

2011
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Adenine; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Organophosphonates; Survival Rate; Treatment Outcome

2011
Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 114, Issue:1

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Infant, Newborn; Lamivudine; Liver Failure; Maternal Mortality; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Time Factors; Treatment Outcome; Uterine Diseases; Virus Replication; Young Adult

2011
Simple scoring system predicting genotypic resistance during rescue therapy for Lamivudine-resistant chronic hepatitis B.
    Journal of clinical gastroenterology, 2012, Volume: 46, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Predictive Value of Tests; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult

2012
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Multivariate Analysis; Republic of Korea; Viremia

2012
Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; Base Sequence; Cloning, Molecular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates

2012
Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Young Adult

2012
[Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2011, Volume: 19, Issue:11

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome

2011
A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged

2012
Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 55, Issue:6

    Topics: Adenine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Treatment Outcome; Viral Load

2012
Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Time Factors

2012
A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.
    Antiviral therapy, 2012, Volume: 17, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Resistance, Viral; Drug Substitution; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prognosis; ROC Curve; Treatment Outcome; Viral Load; Young Adult

2012
Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
    Antiviral therapy, 2013, Volume: 18, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genome, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult

2013
Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:2

    Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Immunoassay; Lamivudine; Male; Middle Aged; Oligonucleotides; Organophosphonates; Prospective Studies; Republic of Korea; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome

2013
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.
    Clinical and molecular hepatology, 2013, Volume: 19, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome

2013
Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy.
    Virus genes, 2013, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Follow-Up Studies; Gene Expression Regulation, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Treatment Outcome; Viral Proteins; Young Adult

2013
Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Treatment Outcome; Viral Load; Young Adult

2013
Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy.
    Virus research, 2013, Nov-06, Volume: 177, Issue:2

    Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; RNA-Directed DNA Polymerase

2013
De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
    World journal of gastroenterology, 2013, Oct-07, Volume: 19, Issue:37

    Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Time Factors; Treatment Outcome

2013
[Therapeutic effect of antiviral regimens for chronic hepatitis B refractory to lamivudine plus adefovir].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:12

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Mutation; Organophosphonates; Real-Time Polymerase Chain Reaction; Recombinant Proteins

2013
Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
    Journal of hepatology, 2014, Volume: 60, Issue:6

    Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Drug Resistance, Viral; End Stage Liver Disease; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Prognosis; Severity of Illness Index

2014
Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2014, Volume: 15, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Egypt; Female; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Young Adult

2014
[Comparative analysis of the efficacies of entecavir capsules and lamivudine in chronic hepatitis B patients].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:12

    Topics: Adult; Antiviral Agents; Double-Blind Method; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Young Adult

2013
[Investigation of entecavir treatment in patients with LAM-refractory chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Failure; Treatment Outcome; Young Adult

2013
Non-interventional study AI463-12 of real-world chronic HBV infection management--baseline characteristics and treatment patterns of Polish patients kohort.
    Przeglad epidemiologiczny, 2013, Volume: 67, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Europe; Female; Guanine; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Poland; Practice Guidelines as Topic; Retrospective Studies; Socioeconomic Factors; Treatment Outcome

2013
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    JAMA, 2014, Dec-17, Volume: 312, Issue:23

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Vincristine; Young Adult

2014
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    World journal of gastroenterology, 2015, Apr-21, Volume: 21, Issue:15

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Biopsy; DNA, Circular; DNA, Viral; Double-Blind Method; Down-Regulation; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Linear Models; Liver; Male; Middle Aged; Time Factors; Treatment Outcome; Viral Load; Young Adult

2015
Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Adenine; Adult; Antiviral Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Telbivudine; Thymidine

2015
A 96-week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Drug Substitution; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Young Adult

2016
A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
    Bone marrow transplantation, 2016, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Allografts; Female; Follow-Up Studies; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Virus Activation

2016
Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Telbivudine; Thymidine; Treatment Outcome

2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.
    The Kaohsiung journal of medical sciences, 2016, Volume: 32, Issue:11

    Topics: Adult; Case-Control Studies; Demography; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors

2016
Effect of nucleoside analogues in the treatment of hepatitis B cirrhosis and its effect on Th17 cell.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:2

    Topics: Adenine; Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Th17 Cells; Treatment Outcome

2017
The ultra-short virological dynamics in response to entecavir or lamivudine during chronic hepatitis B with spontaneous severe acute exacerbation.
    Antiviral therapy, 2018, Volume: 23, Issue:1

    Topics: Adult; Biomarkers; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Viral Load

2018
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Republic of Korea; Sustained Virologic Response; Treatment Outcome; Young Adult

2017
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:13

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Splenomegaly; Thrombocytopenia; Viral Load

2019
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B.
    Scientific reports, 2020, 02-06, Volume: 10, Issue:1

    Topics: Adenine; Adiposity; Antiviral Agents; Cross-Sectional Studies; DNA, Mitochondrial; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Organophosphonates; RNA, Mitochondrial; Tenofovir

2020
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response.
    Clinical and molecular hepatology, 2020, Volume: 26, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Sustained Virologic Response; Telbivudine; Tenofovir

2020
Peginterferon Alfa-2a (40KD) Plus Lamivudine or Entecavir in Children With Immune-Tolerant Chronic Hepatitis B.
    Journal of pediatric gastroenterology and nutrition, 2021, 08-01, Volume: 73, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; Child; DNA, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome

2021
Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use.
    Scientific reports, 2021, 05-13, Volume: 11, Issue:1

    Topics: Absorptiometry, Photon; Adult; Anti-Retroviral Agents; Body Composition; Bone Density; Bone Resorption; Cross-Sectional Studies; Female; Femur Neck; Fibroblast Growth Factor-23; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hip; Humans; Lamivudine; Lumbar Vertebrae; Male; Middle Aged; Osteoclasts; Tenofovir

2021

Other Studies

340 other study(ies) available for lamivudine and guanine

ArticleYear
In vitro evaluation of combination therapies against hepatitis B virus replication.
    Antiviral research, 1996, Volume: 29, Issue:1

    Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine

1996
Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Acyclovir; Antiviral Agents; Cell Line; Dideoxynucleosides; DNA-Directed DNA Polymerase; Guanine; Hepatitis B virus; Hepatoblastoma; Humans; Lamivudine; Microbial Sensitivity Tests; Virus Replication

1996
Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Ducks; Guanine; Hepatitis B Virus, Duck; Lamivudine; Liver; Virus Replication

1997
Combination therapy for chronic hepatitis B.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chronic Disease; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Virus Replication

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006

    Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases

1997
Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.
    Antiviral research, 1998, Volume: 39, Issue:2

    Topics: Acyclovir; Antiviral Agents; Biflavonoids; Cell Line; Drug Synergism; Flavonoids; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Virus Replication

1998
Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.
    Biochemical pharmacology, 1999, Jun-15, Volume: 57, Issue:12

    Topics: Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Zalcitabine

1999
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.
    The Journal of clinical investigation, 1999, Volume: 103, Issue:12

    Topics: Acyclovir; Adenine; Carcinoma, Hepatocellular; Drug Resistance, Microbial; Guanine; Hepatitis B virus; Humans; Lamivudine; Mutagenesis, Site-Directed; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Transfection; Tumor Cells, Cultured

1999
In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cells, Cultured; Drug Interactions; Drug Therapy, Combination; Ducks; Guanine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Organophosphonates; Virus Replication

2000
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture.
    Journal of viral hepatitis, 2000, Volume: 7, Issue:1

    Topics: Acyclovir; Adenine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Guanine; Hepatitis B virus; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir; Tumor Cells, Cultured

2000
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1999, Dec-03, Volume: 41, Issue:1067

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir

1999
Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12

    Topics: Acyclovir; Antigens, Viral; Antiviral Agents; Carcinoma, Hepatocellular; Drug Resistance, Microbial; Guanine; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Microbial Sensitivity Tests; Time Factors; Transfection; Tumor Cells, Cultured; Virus Replication

2000
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Journal of virology, 2001, Volume: 75, Issue:10

    Topics: Acyclovir; Adenine; Amino Acid Sequence; Antiviral Agents; Cytidine Triphosphate; Deoxycytidine; Dideoxynucleotides; Drug Resistance, Microbial; Emtricitabine; Guanine; Hepatitis B virus; Humans; Lamivudine; Models, Molecular; Molecular Sequence Data; Organophosphonates; Protein Conformation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Homology, Amino Acid

2001
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine

2002
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8

    Topics: Antiviral Agents; Blotting, Southern; Capsid Proteins; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Genes, Viral; Genome, Viral; Guanine; Hepatitis B virus; Humans; Kinetics; Lamivudine; Phosphorylation; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication

2002
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Acyclovir; Antiviral Agents; Base Sequence; Deoxyguanosine; Dideoxynucleosides; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Transfection; Tumor Cells, Cultured; Virus Replication

2003
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Adult; Amino Acid Substitution; Antiviral Agents; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Virus Replication

2004
Label-free electrochemical hybridization genosensor for the detection of hepatitis B virus genotype on the development of Lamivudine resistance.
    Analytical chemistry, 2005, Aug-01, Volume: 77, Issue:15

    Topics: Biosensing Techniques; Drug Resistance, Viral; Electrochemistry; Genotype; Guanine; Hepatitis B virus; Lamivudine; Nucleic Acid Hybridization; Oxidation-Reduction

2005
Chronic hepatitis B--treatment with nucleoside analogues.
    The Medical journal of Malaysia, 2005, Volume: 60 Suppl B

    Topics: Adenine; Drug Resistance; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Reverse Transcriptase Inhibitors; Time Factors

2005
Antiviral options for the treatment of chronic hepatitis B.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:6

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates

2006
[The use of nucleotide analogues in treating patients with chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2006, Volume: 14, Issue:5

    Topics: Adenine; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates

2006
[Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2006, Volume: 14, Issue:5

    Topics: Adenine; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates

2006
Hepatitis B virus with primary resistance to adefovir.
    The New England journal of medicine, 2006, Jul-20, Volume: 355, Issue:3

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Organophosphonates; Viral Load

2006
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
    Antiviral research, 2007, Volume: 73, Issue:3

    Topics: Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Drug Synergism; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mycophenolic Acid; Ribavirin; RNA-Directed DNA Polymerase

2007
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
    Journal of hepatology, 2007, Volume: 46, Issue:3

    Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation

2007
Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Salvage Therapy

2007
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir

2007
Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:2

    Topics: Adult; Drug Resistance; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male

2007
Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:5

    Topics: Adult; Amino Acid Motifs; Amino Acid Substitution; Biomarkers; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Probe Techniques; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Viral; Time Factors

2007
The HBV drug entecavir - effects on HIV-1 replication and resistance.
    The New England journal of medicine, 2007, Jun-21, Volume: 356, Issue:25

    Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA, Viral; Virus Replication; Zidovudine

2007
Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire international, 2007, Volume: 16, Issue:90

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome

2007
Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues.
    Journal of medical virology, 2007, Volume: 79, Issue:11

    Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors

2007
[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].
    Medizinische Klinik (Munich, Germany : 1983), 2007, Sep-15, Volume: 102, Issue:9

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Germany; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Telbivudine; Thymidine; United States

2007
[Recent therapies for hepatitis B (discussion)].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:10

    Topics: Adenine; Antiviral Agents; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Organophosphonates

2007
Entecavir: new drug. Chronic hepatitis B: a last resort.
    Prescrire international, 2007, Volume: 16, Issue:91

    Topics: Adult; Antiviral Agents; Europe; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Randomized Controlled Trials as Topic; Treatment Outcome

2007
Successful treatment of an entecavir-resistant hepatitis B virus variant.
    Journal of medical virology, 2007, Volume: 79, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Viral Load

2007
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:12

    Topics: Adult; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Luminescent Measurements; Male; Middle Aged; Necrosis; Statistics as Topic

2007
Hepatitis B: explosion of new knowledge.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Adenine; Antiviral Agents; Disease Progression; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Lamivudine; Organophosphonates

2007
Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients.
    Journal of viral hepatitis, 2007, Volume: 14, Issue:12

    Topics: Antiviral Agents; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Retrospective Studies; RNA-Directed DNA Polymerase

2007
Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Journal of hepatology, 2008, Volume: 48, Issue:3

    Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load

2008
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    Journal of hepatology, 2008, Volume: 48, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Mutation; Phenotype

2008
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
    Journal of hepatology, 2008, Volume: 48, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Nucleotides; Phenotype

2008
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.
    AIDS (London, England), 2008, May-11, Volume: 22, Issue:8

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Evaluation; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Mutation; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; RNA, Viral

2008
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:22

    Topics: Acute Disease; Adenine; Adult; Algorithms; Antiviral Agents; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Middle Aged; Organophosphonates; Prothrombin Time; Transaminases; Treatment Failure; Treatment Outcome

2008
Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Antiviral therapy, 2008, Volume: 13, Issue:3

    Topics: Adenine; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Antiviral Agents; CHO Cells; Cricetinae; Cricetulus; Drug Resistance, Multiple, Viral; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Gene Products, pol; Guanine; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunodominant Epitopes; Lamivudine; Mutagenesis, Site-Directed; Mutation; Organophosphonates; Transfection

2008
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Tenofovir; Viral Load

2008
Immediate allergy, drug-induced eruption, by entecavir.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:4

    Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Hypersensitivity; Guanine; Hepatitis B; Humans; Lamivudine; Male

2009
Changing landscape of antiviral resistance management in chronic hepatitis B.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:9

    Topics: Administration, Oral; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Polymerase Chain Reaction; Predictive Value of Tests; Time Factors; Treatment Failure; Viral Load

2008
Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient.
    Antiviral research, 2009, Volume: 81, Issue:2

    Topics: Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation, Missense; Sequence Analysis, DNA

2009
Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:5

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Retreatment; Treatment Outcome

2008
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
    Journal of hepatology, 2009, Volume: 50, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA Probes; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Sensitivity and Specificity

2009
[Protocol for the antiviral therapy of chronic hepatitis B].
    Orvosi hetilap, 2008, Dec-07, Volume: 149, Issue:49

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2008
[Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B].
    Acta gastroenterologica Latinoamericana, 2008, Volume: 38, Issue:4

    Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Decision Making; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male

2008
Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:5

    Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Decision Support Techniques; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Viral Load; Virus Replication

2008
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
    Journal of hepatology, 2009, Volume: 50, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Treatment Outcome; Viral Load; Young Adult

2009
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4

    Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Viral Proteins; Virus Replication

2009
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:5

    Topics: Amino Acid Substitution; Antiviral Agents; Drug Resistance, Multiple, Viral; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Population Surveillance; Randomized Controlled Trials as Topic; Time Factors

2009
Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:4

    Topics: Adenine; Administration, Oral; Antiviral Agents; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Health Care Costs; Hepatitis B, Chronic; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Markov Chains; Models, Economic; Organophosphonates; Retrospective Studies; Salvage Therapy; Secondary Prevention; Tenofovir; Time Factors; Treatment Failure; Treatment Outcome

2009
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
    American journal of hematology, 2009, Volume: 84, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophosphamide; Doxorubicin; Etoposide; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Stomach; Transplantation, Autologous; Vincristine

2009
Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
    Antiviral chemistry & chemotherapy, 2009, Volume: 19, Issue:4

    Topics: Adenine; Antiviral Agents; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Nucleotides; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine

2009
Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.
    Applied health economics and health policy, 2008, Volume: 6, Issue:4

    Topics: Absenteeism; Analysis of Variance; Anti-HIV Agents; Australia; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Disease Progression; Drug Costs; Forecasting; Guanine; Health Care Costs; Health Services Research; Hepatitis B, Chronic; Humans; Lamivudine; Life Expectancy; Models, Econometric; Quality-Adjusted Life Years; Reverse Transcriptase Inhibitors; Treatment Outcome; Value of Life

2008
Current trends in chronic hepatitis B management: results of a questionnaire.
    European journal of gastroenterology & hepatology, 2009, Volume: 21, Issue:10

    Topics: Adenine; Adult; Antiviral Agents; Biopsy; Clinical Competence; Drug Administration Schedule; Family Health; Guanine; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver; Male; Middle Aged; Organophosphonates; Practice Patterns, Physicians'; Spain; Surveys and Questionnaires

2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results

2009
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Asian People; Base Composition; China; Computational Biology; Databases, Genetic; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Phenotype; Phylogeny; RNA-Directed DNA Polymerase; Treatment Failure; Virus Replication; Young Adult

2009
High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    European journal of haematology, 2009, Volume: 83, Issue:4

    Topics: Adolescent; Adult; Aged; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Plasma Exchange; Risk; Virus Activation; Young Adult

2009
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles.
    Journal of viral hepatitis, 2009, Volume: 16, Issue:12

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Organophosphonates; Prognosis; Pyrimidinones; Retrospective Studies; Telbivudine; Thymidine; Young Adult

2009
Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Adult; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Selection, Genetic; Treatment Outcome

2009
Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.
    Journal of viral hepatitis, 2010, Volume: 17, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Viral Load

2010
Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Journal of HIV therapy, 2009, Volume: 14, Issue:1

    Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine; Transaminases

2009
[Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Case-Control Studies; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Young Adult

2009
[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:10

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Replication

2009
Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.
    Antiviral therapy, 2009, Volume: 14, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Treatment Outcome

2009
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Adult; Antiviral Agents; Computer Simulation; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viral Proteins

2010
[Protocol for the antiviral therapy of hepatitis B and D].
    Orvosi hetilap, 2010, Jan-03, Volume: 151, Issue:1

    Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2010
Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.
    PloS one, 2010, Feb-12, Volume: 5, Issue:2

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Guanine; Guanosine Triphosphate; Hep G2 Cells; Hepatitis B virus; Humans; Hydrogen Bonding; Kinetics; Lamivudine; Models, Molecular; Protein Binding; Protein Structure, Tertiary; RNA-Directed DNA Polymerase; Substrate Specificity; Viral Proteins; Virus Replication

2010
Think twice if you consider entecavir treatment in cases with lamivudine refractoriness.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1

    Topics: Antiviral Agents; Drug Resistance, Multiple, Viral; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Practice Guidelines as Topic

2010
Viral resistance in hepatitis B: prevalence and management.
    Current gastroenterology reports, 2010, Volume: 12, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Phenotype; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2010
Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors.
    Antiviral therapy, 2010, Volume: 15, Issue:3

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Arabinofuranosyluracil; Cell Line; Cells, Cultured; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Microbial Sensitivity Tests; Nucleosides; Nucleotides; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine

2010
Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Asian People; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Logistic Models; Male; Middle Aged; Mutation; Odds Ratio; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load; Young Adult

2010
Resistance management in chronic hepatitis B complicated by renal failure.
    Clinical nephrology, 2010, Volume: 74, Issue:1

    Topics: Adult; Antiviral Agents; Combined Modality Therapy; Contraindications; Drug Resistance; Guanine; Hepatitis B, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male

2010
Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2010, Volume: 13, Issue:5

    Topics: Adenine; Antiviral Agents; China; Cost-Benefit Analysis; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Markov Chains; Models, Economic; Models, Statistical; Monte Carlo Method; Nucleosides; Organophosphonates; Pyrimidinones; Quality-Adjusted Life Years; Reverse Transcriptase Inhibitors; Serologic Tests; Telbivudine; Thymidine

2010
Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
    Transplantation, 2010, Aug-15, Volume: 90, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney Diseases; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load

2010
Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Organophosphonates; Peptide Nucleic Acids; Point Mutation; Sensitivity and Specificity

2010
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 48, Issue:4

    Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Organophosphonates; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Proteins

2010
[Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine

2010
[Genotypic resistance to entecavir in chronic hepatitis B patients].
    The Korean journal of hepatology, 2010, Volume: 16, Issue:2

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Retrospective Studies; RNA-Directed DNA Polymerase

2010
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; Asian People; DNA, Circular; DNA, Viral; Drug Resistance; Female; Gene Products, pol; Genetic Variation; Genome, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phylogeny; Tenofovir; Trans-Activators; Viral Envelope Proteins; Viral Regulatory and Accessory Proteins; Virus Replication

2011
Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
    Journal of hepatology, 2010, Volume: 53, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genes, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Viral Load

2010
Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:8

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load; Virus Replication

2010
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:10

    Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Disease-Free Survival; Female; Guanine; Hepatectomy; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Kaplan-Meier Estimate; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organophosphonates; Proportional Hazards Models; Risk Assessment; Risk Factors; RNA, Viral; Survival Rate; Time Factors; Treatment Outcome

2010
[Treatment of chronic hepatitis B. High response rate in general practice].
    MMW Fortschritte der Medizin, 2010, Jul-22, Volume: 152, Issue:28-30

    Topics: Adenine; Antiviral Agents; Cross-Sectional Studies; Germany; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Long-Term Care; Organophosphonates; Patient Care Team; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load

2010
Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:11

    Topics: Adenine; Antiviral Agents; Cell Line, Tumor; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Organophosphonates; Polymorphism, Single Nucleotide; Tenofovir; Viral Load; Viral Proteins; Virus Replication

2011
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B.
    Journal of hepatology, 2011, Volume: 54, Issue:1

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Cohort Studies; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Young Adult

2011
Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies.
    Cellular & molecular immunology, 2011, Volume: 8, Issue:1

    Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Case-Control Studies; Cytokines; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunomodulation; Lamivudine; Male; Middle Aged; Organophosphonates; T-Lymphocytes, Regulatory; Th1-Th2 Balance

2011
Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
    Journal of virological methods, 2011, Volume: 171, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Viral Proteins

2011
Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.
    Journal of hepatology, 2011, Volume: 54, Issue:2

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Virus Activation

2011
[Analogs combination therapy in chronic hepatitis B: when and how?].
    Gastroenterologie clinique et biologique, 2010, Volume: 34 Suppl 2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
    Gastroenterologie clinique et biologique, 2010, Volume: 34 Suppl 2

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine

2010
[Treatment has a positive impact on the long-term evolution of chronic hepatitis B].
    Gastroenterologie clinique et biologique, 2010, Volume: 34 Suppl 2

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2010
Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Antiviral therapy, 2010, Volume: 15, Issue:8

    Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; China; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Typing; Mutation, Missense; Nucleosides; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Young Adult

2010
Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.
    Antiviral therapy, 2010, Volume: 15, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Evolution, Molecular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Organophosphonates; Phylogeny; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome

2010
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3

    Topics: Adenine; Antiviral Agents; Combined Modality Therapy; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Perioperative Care; Secondary Prevention; Tenofovir; Treatment Outcome

2011
[Lamivudine and entecavir significantly improved the prognosis of early-to-mid stage hepatitis B related acute on chronic liver failure].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2010, Volume: 24, Issue:3

    Topics: Anti-HIV Agents; Disease Susceptibility; End Stage Liver Disease; Guanine; Humans; Lamivudine; Prognosis

2010
Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome

2011
Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2011
Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
    Gut, 2011, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Genetic Variation; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Retrospective Studies; RNA-Directed DNA Polymerase; Selection, Genetic; Sequence Analysis, DNA; Treatment Outcome; Young Adult

2011
[Efficacy of entecavir and adefovir combination therapy in patients with chronic hepatitis B refractory to lamivudine and adefovir combination therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates

2011
Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.
    Antiviral therapy, 2011, Volume: 16, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mass Spectrometry; Mutation; Organophosphonates; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Viral Load

2011
LC-ESI-MS/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Apr-01, Volume: 879, Issue:11-12

    Topics: Analysis of Variance; Antiviral Agents; Area Under Curve; Chromatography, Liquid; Drug Stability; Guanine; Humans; Lamivudine; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency

2011
Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
    Antiviral therapy, 2011, Volume: 16, Issue:3

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepacivirus; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-gamma; Lamivudine; Male; Middle Aged; Nucleosides; Organophosphonates; Predictive Value of Tests; Pyrimidinones; T-Lymphocytes; Telbivudine; Thymidine; Treatment Outcome; Up-Regulation; Young Adult

2011
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
    Alimentary pharmacology & therapeutics, 2011, Volume: 34, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Real-Time Polymerase Chain Reaction; Recurrence; Time Factors

2011
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.
    Archives of surgery (Chicago, Ill. : 1960), 2011, Volume: 146, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Guanine; Hepatectomy; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate

2011
Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations.
    BMC infectious diseases, 2011, Jun-22, Volume: 11

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Evolution, Molecular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Middle Aged; Mutation; Organophosphonates; Tenofovir; Treatment Failure

2011
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Adenine; Animals; Antiviral Agents; Biological Availability; Drug Design; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mice; Models, Chemical; Molecular Structure; Mutation; Organophosphonates; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tenofovir; Tetrazoles

2011
Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Alimentary pharmacology & therapeutics, 2011, Volume: 34, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome

2011
Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:10

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome; Viral Load

2011
Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:10

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Salvage Therapy; Treatment Outcome

2011
Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Clinical and experimental medicine, 2012, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; End Stage Liver Disease; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult

2012
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B.
    Journal of medical virology, 2012, Volume: 84, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Viral Load

2012
Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2011, Volume: 25, Issue:10

    Topics: Adenine; Antiviral Agents; Canada; Drug Approval; Guanine; Health Services Accessibility; Hepatitis B, Chronic; Humans; Insurance Coverage; Lamivudine; Liver Cirrhosis; National Health Programs; Organophosphonates; Tenofovir

2011
Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2012, Volume: 53, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Cell Line, Tumor; Drug Resistance, Multiple, Viral; Fatal Outcome; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Mutation; Organophosphonates; Virus Replication

2012
Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:12

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Female; Guanine; Hepatectomy; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male

2011
Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:3

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Time Factors; Young Adult

2012
Efficacy of entecavir and adefovir combination therapy for patients with lamivudine- and entecavir-resistant chronic hepatitis B.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organophosphonates; Treatment Outcome; Viral Load; Virus Replication

2012
Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:7

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; DNA, Viral; Drug Costs; Drug Resistance, Viral; Guanine; Health Care Costs; Hepatitis B virus; Hepatitis B, Chronic; Hong Kong; Hospitals, Public; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Quality-Adjusted Life Years; Viral Load

2012
Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.
    International journal of medical sciences, 2012, Volume: 9, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors

2012
Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
    Journal of medical virology, 2012, Volume: 84, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Treatment Outcome; Viral Load

2012
Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.
    Journal of vascular and interventional radiology : JVIR, 2012, Volume: 23, Issue:3

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Disease-Free Survival; Female; Guanine; Hepatitis B, Chronic; Humans; Japan; Kaplan-Meier Estimate; Lamivudine; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Nucleosides; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome

2012
Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.
    Antiviral therapy, 2012, Volume: 17, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Treatment Failure; Viral Load

2012
High-resolution melting and real-time PCR for quantification and detection of drug-resistant HBV mutants in a single amplicon.
    Antiviral therapy, 2012, Volume: 17, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Complementary; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Molecular Diagnostic Techniques; Nucleic Acid Denaturation; Organophosphonates; Pilot Projects; Polymerase Chain Reaction; Viral Load

2012
Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome

2012
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Orvosi hetilap, 2012, Mar-11, Volume: 153, Issue:10

    Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome

2012
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Retrospective Studies; Treatment Failure

2012
Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Severity of Illness Index

2012
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.
    Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viral Load; Young Adult

2012
Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Genome, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; High-Throughput Nucleotide Sequencing; Humans; Lamivudine; Liver; Male; Middle Aged

2012
Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient.
    Intervirology, 2012, Volume: 55, Issue:5

    Topics: Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense

2012
Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
    Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:12

    Topics: Adenine; Antiviral Agents; Drug Resistance; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir

2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Young Adult

2012
Current practice of chronic hepatitis B treatment in Southern Italy.
    European journal of internal medicine, 2012, Volume: 23, Issue:5

    Topics: Adenine; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Italy; Lamivudine; Male; Middle Aged; Nucleosides; Organophosphonates; Polyethylene Glycols; Practice Patterns, Physicians'; Pyrimidinones; Recombinant Proteins; Telbivudine; Tenofovir; Thymidine; Young Adult

2012
Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:10

    Topics: Antiviral Agents; Drug Resistance, Viral; Guanine; Haplotypes; Hepatitis B; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Lamivudine; Mutation; Reproducibility of Results

2012
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Gastroenterology, 2012, Volume: 143, Issue:4

    Topics: Adenine; Antiviral Agents; Cells, Cultured; DNA, Viral; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-gamma; Interleukin-1; Lamivudine; Organophosphonates; T-Lymphocytes; Tenofovir; Tumor Necrosis Factor-alpha

2012
Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: a report of two cases.
    Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Guanine; Hepatitis B, Chronic; Histocytochemistry; Humans; Lamivudine; Liver Failure, Acute; Liver Transplantation; Male; Medication Adherence; Necrosis; Organophosphonates; Telbivudine; Thymidine

2013
Comparison of rescue strategies in lamivudine-resistant patients with chronic hepatitis B.
    Antiviral research, 2012, Volume: 96, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; China; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Salvage Therapy; Treatment Outcome

2012
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
    Journal of hepatology, 2013, Volume: 58, Issue:2

    Topics: Acute Disease; Adenine; Adult; Antiviral Agents; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Male; Mutation; Organophosphonates; Retrospective Studies; Sequence Analysis, DNA; United States

2013
Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?
    Journal of medical virology, 2013, Volume: 85, Issue:1

    Topics: Adult; Antiviral Agents; Asia; Blood Chemical Analysis; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Mutation Rate; Mutation, Missense; RNA-Directed DNA Polymerase; Treatment Outcome; Viral Load

2013
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Antiviral research, 2012, Volume: 96, Issue:3

    Topics: Adenine; Administration, Oral; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Genes, pol; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Mutation Rate; Organophosphonates; Prevalence; Virus Replication

2012
Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:1

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Blood Chemical Analysis; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Turkey

2013
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
    The Netherlands journal of medicine, 2012, Volume: 70, Issue:8

    Topics: Adenine; Antiviral Agents; Drug Approval; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Netherlands; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Telbivudine; Tenofovir; Thymidine

2012
Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
    Journal of medical virology, 2013, Volume: 85, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; Clonal Evolution; DNA, Viral; Drug Resistance, Multiple, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; RNA-Directed DNA Polymerase

2013
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis.
    Journal of hepatology, 2013, Volume: 58, Issue:3

    Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antiviral Agents; Child; Child, Preschool; Female; Follow-Up Studies; Guanine; Hepatitis B Core Antigens; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Proportional Hazards Models

2013
The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovir.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Failure

2013
The short-term efficacy of entecavir in lamivudine-resistant chronic hepatitis B: influence of sequential adefovir-refractoriness.
    Hepato-gastroenterology, 2013, Volume: 60, Issue:124

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome

2013
Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.
    Scandinavian journal of gastroenterology, 2013, Volume: 48, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Retrospective Studies; Treatment Outcome; Viral Load

2013
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.
    Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:1

    Topics: Adult; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies

2013
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely.
    Journal of hepatology, 2013, Volume: 58, Issue:4

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kinetics; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Tenofovir

2013
2'-Fluoro-6'-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: in vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action.
    Bioorganic & medicinal chemistry letters, 2013, Jan-15, Volume: 23, Issue:2

    Topics: Adenosine; Antiviral Agents; Binding Sites; Cells, Cultured; Drug Resistance, Viral; Guanine; Hepatitis B virus; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Lamivudine; Models, Molecular; Molecular Structure; Mutation; Prodrugs; Thermodynamics

2013
Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load.
    Annals of surgical oncology, 2013, Volume: 20, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Organophosphonates; Portal Vein; Proportional Hazards Models; Retrospective Studies; Risk Factors; Viral Load

2013
Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.
    The Korean journal of internal medicine, 2012, Volume: 27, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Viral; Female; Glomerulonephritis, Membranous; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Young Adult

2012
Treatment of hepatitis B virus reactivation in a cadaveric renal transplant recipient with entecavir.
    Arab journal of nephrology and transplantation, 2013, Volume: 6, Issue:1

    Topics: Adolescent; Antiviral Agents; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Virus Activation

2013
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:4

    Topics: Adenine; Aged; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kinetics; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2013
Outcome of various treatments for posttransplant hepatitis B virus recurrence.
    World journal of surgery, 2013, Volume: 37, Issue:4

    Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2013
High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Journal of medical virology, 2013, Volume: 85, Issue:5

    Topics: Adenine; Antiviral Agents; Codon, Nonsense; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Organophosphonates; RNA-Directed DNA Polymerase

2013
Increased eGFR with telbivudine in combination therapy of chronic hepatitis B infection.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Telbivudine; Tenofovir; Thymidine

2014
Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:8

    Topics: Aged; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Female; Guanine; Hematologic Diseases; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Patient Selection; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Virus Activation

2013
Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine.
    International journal of medical sciences, 2013, Volume: 10, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Retrospective Studies

2013
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Transplantation, 2013, Apr-15, Volume: 95, Issue:7

    Topics: Adenine; Adult; Aged; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Donor Selection; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Logistic Models; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome; Viral Load

2013
Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:2

    Topics: Administration, Oral; Adult; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Administration Schedule; End Stage Liver Disease; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome

2013
Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patients.
    International journal of medical sciences, 2013, Volume: 10, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies

2013
Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
    Antiviral therapy, 2014, Volume: 19, Issue:3

    Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Disease Management; DNA, Viral; Europe; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Tenofovir

2014
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
    Journal of medical virology, 2013, Volume: 85, Issue:6

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Recurrence; Telbivudine; Thymidine; Treatment Outcome

2013
Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B.
    The American journal of gastroenterology, 2013, Volume: 108, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Care; Proportional Hazards Models; Secondary Prevention; Survival Rate; Viral Load; Young Adult

2013
[Anti-HBV effect of nucleotide analogues on mouse model of chronic HBV infection mediated by recombinant adeno-associated virus 8].
    Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2013, Volume: 29, Issue:1

    Topics: Animals; Antiviral Agents; Dependovirus; Disease Models, Animal; Genetic Vectors; Genome, Viral; Guanine; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Lamivudine; Mice; Mice, Inbred C57BL; Nucleotides; Transduction, Genetic; Virus Replication

2013
Comparison of re-treatment outcomes of lamivudine plus adefovir or entecavir in chronic hepatitis B patients with viral relapse after cessation of adefovir.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; Case-Control Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Organophosphonates; Prospective Studies; Recurrence; Treatment Outcome

2013
Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era?
    The American journal of gastroenterology, 2013, Volume: 108, Issue:6

    Topics: Adenine; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Organophosphonates

2013
Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
    Antiviral therapy, 2013, Volume: 18, Issue:8

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Recurrence; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Viral Load; Young Adult

2013
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:9

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome

2013
Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:1

    Topics: Adult; Antiviral Agents; Cohort Studies; Disease Progression; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Risk Factors; Time Factors; Young Adult

2014
[Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:3

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Young Adult

2013
Long-term efficacy of entecavir plus adefovir combination therapy versus entecavir monotherapy in adefovir refractory chronic hepatitis B patients with prior lamivudine resistance.
    Intervirology, 2014, Volume: 57, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome

2014
Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: a pilot study.
    Medical science monitor : international medical journal of experimental and clinical research, 2013, Sep-09, Volume: 19

    Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Pilot Projects

2013
Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:2

    Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Viral; Female; France; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Prospective Studies; Time Factors; Treatment Outcome; Viral Load; Virus Replication

2014
Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Adenine; Adult; Aged; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome

2013
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:3

    Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; Drug Therapy, Combination; End Stage Liver Disease; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Risk Factors; Secondary Prevention; Sex Factors; Tyrosine

2014
Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors.
    Transplant international : official journal of the European Society for Organ Transplantation, 2013, Volume: 26, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Tissue Donors

2013
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
    Gut, 2014, Volume: 63, Issue:8

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Time Factors

2014
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:5

    Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Republic of Korea; Telbivudine; Thymidine; Time Factors; Treatment Outcome

2014
Restoration of albumin production by nucleoside analogue therapy in patients with chronic hepatitis B.
    Medical molecular morphology, 2014, Volume: 47, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Female; Gene Expression; Guanine; Hepatitis B, Chronic; Hepatocyte Growth Factor; Humans; Lamivudine; Liver; Male; Middle Aged; Serum Albumin; Transforming Growth Factor beta1; Young Adult

2014
Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
    Antiviral therapy, 2014, Volume: 19, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Europe; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hospitalization; Humans; Insurance, Health, Reimbursement; Interferon-alpha; Lamivudine; Longitudinal Studies; Male; Middle Aged; Monitoring, Ambulatory; Organophosphonates; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Tenofovir

2014
Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis.
    Revista de saude publica, 2013, Volume: 47, Issue:4

    Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; Brazil; Cost-Benefit Analysis; Disease Progression; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Markov Chains; Organophosphonates; Tenofovir; Treatment Outcome

2013
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Cohort Studies; Dihydropyridines; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Patient Compliance; Prospective Studies; Taiwan; Time Factors; Young Adult

2014
Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Viral Load

2014
Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Time Factors; Treatment Outcome; Viral Load

2014
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data.
    Clinical and molecular hepatology, 2013, Volume: 19, Issue:4

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies

2013
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:3

    Topics: Adenine; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Follow-Up Studies; Graft Survival; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Markov Chains; Organophosphonates; Prognosis; Quality-Adjusted Life Years; Survival Rate; Tenofovir

2014
Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
    BMC infectious diseases, 2014, Feb-14, Volume: 14

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Prospective Studies; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Viral Load; Young Adult

2014
[Loss of hbs antigen after treatment with analogues: infrequent but stable and beneficial].
    La Revue du praticien, 2013, Volume: 63, Issue:10

    Topics: Antiviral Agents; Asian People; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Prognosis; Republic of Korea; Treatment Outcome

2013
Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
    Gastroenterology, 2014, Volume: 147, Issue:1

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome

2014
Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus.
    Journal of virological methods, 2014, Volume: 201

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Organophosphonates; Tenofovir; Virus Replication

2014
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
    Gut, 2014, Volume: 63, Issue:12

    Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Kaplan-Meier Estimate; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Patient Acuity; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time

2014
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Telbivudine; Thymidine; Time Factors; Virus Activation; Withholding Treatment

2014
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Orvosi hetilap, 2014, Volume: 155 Suppl

    Topics: Adenine; Antiviral Agents; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Hungary; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2014
The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.
    Journal of hepatology, 2014, Volume: 60, Issue:6

    Topics: Acute-On-Chronic Liver Failure; End Stage Liver Disease; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male

2014
Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:9

    Topics: Administration, Oral; Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Arabinofuranosyluracil; Biomarkers; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Time Factors

2014
On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy.
    Antiviral therapy, 2015, Volume: 20, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prognosis; RNA, Viral; Treatment Outcome; Viral Load

2015
HBV mutations associated with lamivudine therapy.
    Przeglad epidemiologiczny, 2013, Volume: 67, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cross Reactions; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Gene Products, pol; Genetic Variation; Guanine; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Point Mutation; Reverse Transcriptase Inhibitors; Viral Load; Young Adult

2013
Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load

2014
Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    World journal of gastroenterology, 2014, Apr-28, Volume: 20, Issue:16

    Topics: Acute-On-Chronic Liver Failure; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; China; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Viral Load; Virus Activation

2014
Entecavir treatment in kidney transplant recipients infected with hepatitis B.
    Clinical transplantation, 2014, Volume: 28, Issue:9

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Glomerular Filtration Rate; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Function Tests; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Transplant Recipients

2014
Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Antiviral therapy, 2015, Volume: 20, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; China; Clone Cells; Drug Resistance, Viral; Female; Gene Expression; Genotype; Guanine; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Organophosphonates; Phenotype; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Proteins

2015
Adefovir and lamivudine combination therapy in patients with entecavir-resistant chronic hepatitis B: antiviral responses and evolution of mutations.
    Intervirology, 2014, Volume: 57, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Serum; Treatment Outcome; Viral Load

2014
Antiviral therapy of chronic hepatitis B.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Gene Products, pol; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Replication

2014
Therapy of acute and fulminant hepatitis B.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver; Liver Failure, Acute; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine

2014
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Viral Load; Viremia

2014
Mechanisms of hepatitis B virus resistance development.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Amino Acid Substitution; Antiviral Agents; Deoxycytidine; Drug Resistance, Multiple, Viral; Emtricitabine; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Telbivudine; Tenofovir; Thymidine; Virus Replication

2014
Hepatitis B virus drug resistance tools: one sequence, two predictions.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Antiviral Agents; Base Sequence; Drug Resistance, Multiple, Viral; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Evasion; Lamivudine; Microbial Sensitivity Tests; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Telbivudine; Tenofovir; Thymidine

2014
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.
    Journal of viral hepatitis, 2015, Volume: 22, Issue:2

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Greece; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Risk Assessment; Treatment Outcome

2015
Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.
    Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Withholding Treatment; Young Adult

2014
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs.
    BMC infectious diseases, 2014, Aug-13, Volume: 14

    Topics: Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Outcome

2014
[Retrospective analysis of the efficacy and safety of anti-hepatitis B virus drugs taken during pregnancy in women from the Guangdong Province].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:7

    Topics: Adenine; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Mothers; Organophosphonates; Pregnancy; Retrospective Studies; Telbivudine; Thymidine; Time Factors

2014
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
    Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:11-12

    Topics: Adenine; Adult; Antiviral Agents; Canada; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleosides; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine; Tenofovir; Thymidine

2014
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.
    Clinical and molecular hepatology, 2014, Volume: 20, Issue:3

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Treatment Outcome

2014
Partial virological response to three different nucleotide analogues in naive patients with chronic hepatitis B.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2014, Volume: 13, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2014
[Tenofovir rescue therapy for chronic hepatitis B patients after suboptimal response to treatment with lamivudine plus adefovir dipivoxil].
    Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Failure; Treatment Outcome

2014
Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.
    JAMA, 2014, Dec-17, Volume: 312, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male

2014
Hepatitis B virus DNA negativity acts as a favorable prognostic factor in hepatocellular carcinoma patients.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Child; Disease-Free Survival; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Young Adult

2014
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:8

    Topics: Adult; Antiviral Agents; Cohort Studies; Comorbidity; Disease Progression; Female; France; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tenofovir; Treatment Outcome

2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
    Antiviral therapy, 2015, Volume: 20, Issue:8

    Topics: Antiviral Agents; Cell Line, Tumor; Cells, Cultured; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Microbial Sensitivity Tests; Mutation; Virus Replication

2015
HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
    Antiviral therapy, 2015, Volume: 20, Issue:4

    Topics: Adenine; Antibodies, Viral; Antiviral Agents; Brazil; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; Organophosphonates; Retrospective Studies; Sequence Analysis, DNA; Tenofovir; Virus Replication

2015
Thymosin alpha-1 treatment in chronic hepatitis B.
    Expert opinion on biological therapy, 2015, Volume: 15 Suppl 1

    Topics: Adjuvants, Immunologic; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Thymalfasin; Thymosin; Virus Replication

2015
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
    Journal of medical virology, 2015, Volume: 87, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Promoter Regions, Genetic; Prospective Studies; Republic of Korea; Viral Core Proteins; Virus Replication

2015
Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
    Journal of medical virology, 2015, Volume: 87, Issue:6

    Topics: Adenine; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; High-Throughput Nucleotide Sequencing; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; ROC Curve; Tenofovir; Treatment Failure; Treatment Outcome

2015
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine.
    The new microbiologica, 2015, Volume: 38, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Viral Matrix Proteins; Young Adult

2015
[Nucleoside analogues for acute-on-chronic liver failure associated with hepatitis B virus infection: a 24-month survival analysis].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:1

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Cohort Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Prospective Studies; Survival Analysis; Survival Rate; Telbivudine; Thymidine; Time Factors

2015
[Pharmacoeconomic evaluation of treatments based on antiretrovirals for HBeAg-negative chronic hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:1

    Topics: Adenine; Antiviral Agents; China; Cost-Benefit Analysis; Economics, Pharmaceutical; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Polyethylene Glycols; Quality-Adjusted Life Years; Recombinant Proteins

2015
Efficacy of entecavir treatment among chronic hepatitis B nucleos(t)ide-naïve and -experienced patients.
    Turkish journal of medical sciences, 2015, Volume: 45, Issue:1

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Viral Load

2015
Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:11

    Topics: Adenine; Adult; Antiviral Agents; Clonal Evolution; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Viral Load

2015
Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.
    Medicine, 2015, Volume: 94, Issue:15

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Retrospective Studies; Telbivudine; Thymidine

2015
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir.
    Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:10

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Tenofovir; Treatment Failure

2015
Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
    Journal of medical virology, 2015, Volume: 87, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Female; Genetic Variation; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Prevalence; RNA-Directed DNA Polymerase; Telbivudine; Thymidine; Time Factors; Young Adult

2015
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients.
    Journal of pharmaceutical and biomedical analysis, 2015, Oct-10, Volume: 114

    Topics: Antiviral Agents; Calibration; Chemistry Techniques, Analytical; Chromatography; Chromatography, High Pressure Liquid; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Nucleosides; Reproducibility of Results; Tandem Mass Spectrometry; Telbivudine; Tenofovir; Thymidine

2015
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Antiviral Agents; Demography; DNA, Viral; Female; Guanine; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Treatment Outcome; Virus Activation; Withholding Treatment

2015
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients.
    Clinical and molecular hepatology, 2015, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Remission Induction; Retrospective Studies; Young Adult

2015
Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis.
    Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:4

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Tenofovir

2015
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.
    Clinical and experimental medicine, 2016, Volume: 16, Issue:3

    Topics: Adenine; Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Blood; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Treatment Outcome; Viral Load; Young Adult

2016
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Adenine; Amino Acid Substitution; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Drug Resistance, Multiple, Viral; Gene Products, pol; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Organophosphonates; Tenofovir; Virus Replication

2015
Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
    World journal of gastroenterology, 2015, Aug-28, Volume: 21, Issue:32

    Topics: Adult; Antiviral Agents; Biopsy; Chi-Square Distribution; China; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load

2015
Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients.
    Journal of viral hepatitis, 2016, Volume: 23, Issue:6

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Seroconversion; Treatment Outcome; Young Adult

2016
Long-term follow-up of HBsAg-positive patients in Germany.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1

    Topics: Adenine; Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mass Screening; Middle Aged; Organophosphonates; Prognosis; Prospective Studies; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Turkey

2016
Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies.
    World journal of gastroenterology, 2015, Oct-14, Volume: 21, Issue:38

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Viral Load; Young Adult

2015
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Clinical and molecular hepatology, 2015, Volume: 21, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Odds Ratio; Organophosphonates; Real-Time Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load

2015
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:1

    Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients

2016
Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patients.
    Clinics and research in hepatology and gastroenterology, 2016, Volume: 40, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Hospitalization; Humans; Lamivudine; Male; Organophosphonates; Prospective Studies; Telbivudine; Thymidine; Treatment Outcome

2016
Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China.
    Scientific reports, 2015, Nov-27, Volume: 5

    Topics: Adenine; Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Ethnicity; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Epidemiology; Mutation; Organophosphonates; Prevalence

2015
Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand.
    BMC pharmacology & toxicology, 2015, Dec-14, Volume: 16

    Topics: Adenine; Adult; Antiviral Agents; Creatinine; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Hospitals; Humans; Incidence; Kidney Diseases; Lamivudine; Male; Middle Aged; Nephrons; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Telbivudine; Tenofovir; Thailand; Thymidine; Tropical Medicine

2015
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.
    Journal of gastroenterology, 2016, Volume: 51, Issue:8

    Topics: Administration, Oral; Adult; Age Factors; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Withholding Treatment; Young Adult

2016
A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Antiviral research, 2016, Volume: 126

    Topics: Antiviral Agents; Cell Line; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genetic Complementation Test; Genetic Predisposition to Disease; Guanine; HEK293 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inhibitory Concentration 50; Lamivudine; Lentivirus; Mutation; Nucleotides; Real-Time Polymerase Chain Reaction; RNA Viruses; Transduction, Genetic; Virus Replication

2016
Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients.
    The Kaohsiung journal of medical sciences, 2016, Volume: 32, Issue:1

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2016
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.
    Acta medica Okayama, 2016, Volume: 70, Issue:1

    Topics: Age Factors; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Reverse Transcriptase Inhibitors

2016
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    Journal of medical virology, 2016, Volume: 88, Issue:9

    Topics: Adult; Alanine Transaminase; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Assessment; Viral Load; Virus Activation

2016
[Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, Volume: 24, Issue:1

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Organophosphonates; Polymerase Chain Reaction; Telbivudine; Tenofovir; Thymidine

2016
Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B.
    BMC gastroenterology, 2016, Mar-17, Volume: 16

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Remission Induction; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load

2016
Profile of HBV polymerase gene mutations during entecavir treatment in patients with chronic hepatitis B.
    Clinics and research in hepatology and gastroenterology, 2016, Volume: 40, Issue:5

    Topics: Adenine; Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Viral Load; Young Adult

2016
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
    Oncotarget, 2016, May-10, Volume: 7, Issue:19

    Topics: Adenine; Administration, Oral; Adolescent; Adult; Amino Acid Sequence; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; DNA, Circular; Drug Resistance, Viral; Fatty Liver; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Liver; Liver Neoplasms; Male; Middle Aged; Necrosis; Organophosphonates; Protein Precursors; Sequence Deletion; Viral Load; Young Adult

2016
[Effect of IL-28B polymorphisms on the natural course of HBV infection].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Adult; Antiviral Agents; Carrier State; Female; Guanine; Hepatitis B, Chronic; Humans; Interferons; Interleukins; Lamivudine; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Real-Time Polymerase Chain Reaction; Telbivudine; Tenofovir; Thymidine; Turkey

2016
De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.
    Annals of clinical microbiology and antimicrobials, 2016, Apr-14, Volume: 15

    Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Viral Proteins

2016
Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
    Clinical and experimental medicine, 2017, Volume: 17, Issue:2

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Retrospective Studies; Seroconversion; Telbivudine; Thymidine; Treatment Outcome; Viral Load

2017
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:7

    Topics: Adenine; Aged; Antiviral Agents; Cryoglobulinemia; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Vasculitis

2016
Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals.
    Journal of clinical gastroenterology, 2016, Volume: 50, Issue:8

    Topics: Adult; Antiviral Agents; Ascites; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Prothrombin Time; Retrospective Studies; Serum Albumin

2016
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2016, Volume: 27, Issue:3

    Topics: Adult; Age Factors; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Sustained Virologic Response; Tenofovir; Time Factors; Treatment Outcome

2016
Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China.
    Hepatology international, 2016, Volume: 10, Issue:6

    Topics: Adenine; Antiviral Agents; Cost-Benefit Analysis; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Markov Chains; Organophosphonates; Quality-Adjusted Life Years; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2016
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Gut and liver, 2016, Nov-15, Volume: 10, Issue:6

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Propensity Score; Retrospective Studies; Risk Factors; Treatment Outcome

2016
Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:2

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Phosphorous Acids; Platelet Count; Proportional Hazards Models; Risk Factors; ROC Curve; Time Factors

2017
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:11

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Propensity Score; Retrospective Studies; Treatment Outcome

2016
A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients.
    Scientific reports, 2016, 07-01, Volume: 6

    Topics: Adenine; Adult; Antiviral Agents; Asian People; China; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load

2016
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
    Clinical transplantation, 2016, Volume: 30, Issue:10

    Topics: Adenine; Administration, Oral; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunologic Factors; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Proportional Hazards Models; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome

2016
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Withholding Treatment; Young Adult

2016
Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
    Asia-Pacific journal of clinical oncology, 2016, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Cytotoxins; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Virus Activation; Young Adult

2016
[HBsAg clearance rate in patients with HBeAg-positive chronic hepatitis B: a comparative effect analysis based on the real world].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, May-20, Volume: 24, Issue:5

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome

2016
Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues.
    Journal of viral hepatitis, 2016, Volume: 23, Issue:12

    Topics: Adult; Antiviral Agents; Drug Monitoring; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load

2016
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study.
    Gut and liver, 2017, Jan-15, Volume: 11, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; Cohort Studies; Disease Management; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Viral Load

2017
Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Adult; Antiviral Agents; Bayes Theorem; Cost-Benefit Analysis; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Monte Carlo Method; Quality-Adjusted Life Years; Treatment Outcome

2016
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment.
    Clinical and molecular hepatology, 2016, Volume: 22, Issue:3

    Topics: Adenine; Adult; Alanine Transaminase; Antibodies, Viral; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome

2016
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:1

    Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Decision Support Techniques; Drug Resistance, Viral; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome

2017
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    Journal of viral hepatitis, 2017, Volume: 24, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Treatment Outcome; Viral Load; Young Adult

2017
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
    Gut and liver, 2016, 11-15, Volume: 10, Issue:6

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Treatment Outcome

2016
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
    Gut, 2018, Volume: 67, Issue:2

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asymptomatic Infections; Carcinoma, Hepatocellular; Culture Media, Conditioned; DNA, Viral; Female; Gene Expression; Genotype; Guanine; Hep G2 Cells; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HT29 Cells; Humans; Interferons; Interleukins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Polymorphism, Genetic; Recombinant Proteins; Tenofovir; Up-Regulation; Young Adult

2018
Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North China.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; China; Cohort Studies; Drug Resistance, Multiple, Viral; Female; Gene Expression; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Middle Aged; Mutation Rate; Organophosphonates; Phylogeny; Viral Proteins

2017
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy.
    Journal of medical virology, 2017, Volume: 89, Issue:7

    Topics: Adenine; Aged; Antiviral Agents; Cross-Sectional Studies; Cytosine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA, Mitochondrial; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Nucleosides; Organophosphonates; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine

2017
Comparative evaluation of long-term monotherapies & combination therapies in patients with chronic hepatitis B: A pilot study.
    The Indian journal of medical research, 2016, Volume: 144, Issue:3

    Topics: Adenine; Adult; Drug Combinations; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Pilot Projects; Tenofovir

2016
Influence of Treg cells and HBV genotype on sustained response and drug resistance in the treatment with nucleoside drugs.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2017, Mar-02, Volume: 50, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Drug Resistance; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Sustained Virologic Response; T-Lymphocytes, Regulatory; Time Factors

2017
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.
    Antiviral research, 2017, Volume: 143

    Topics: Adenine; Antiviral Agents; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Evolution, Molecular; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Organophosphonates; Polymorphism, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis; Tenofovir; Treatment Failure

2017
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    The American journal of gastroenterology, 2017, Volume: 112, Issue:6

    Topics: Adult; Antiviral Agents; Aspartate Aminotransferases; Carcinoma, Hepatocellular; DNA, Viral; Elasticity Imaging Techniques; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prospective Studies; Severity of Illness Index

2017
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.
    Antiviral therapy, 2018, Volume: 23, Issue:1

    Topics: Amino Acid Substitution; Antiviral Agents; Biomarkers; Cell Line; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; RNA-Directed DNA Polymerase; Virus Replication

2018
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:10

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Practice Guidelines as Topic; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load

2017
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir.
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Area Under Curve; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; ROC Curve; Tenofovir; Treatment Outcome

2017
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:9

    Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lactic Acid; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Risk Factors; Sex Factors; Tenofovir; Time Factors; Treatment Outcome; Up-Regulation; Young Adult

2017
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:3

    Topics: Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Tenofovir

2017
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up.
    Journal of the Chinese Medical Association : JCMA, 2017, Volume: 80, Issue:12

    Topics: Aged; Antineoplastic Agents; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies

2017
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:2

    Topics: Adult; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; End Stage Liver Disease; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Republic of Korea; ROC Curve; Severity of Illness Index; Tenofovir; Treatment Outcome

2018
Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Nov-02, Volume: 23

    Topics: Adenine; Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Multivariate Analysis; Nucleosides; Organophosphonates; Proportional Hazards Models; Telbivudine; Thymidine

2017
Lamivudine: fading into the mists of time.
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:4

    Topics: Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine

2017
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:4

    Topics: Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Mutation

2017
Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray.
    Gut and liver, 2018, May-15, Volume: 12, Issue:3

    Topics: Adenine; Dendrimers; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microarray Analysis; Mutation; Nucleic Acid Amplification Techniques; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction

2018
Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:9

    Topics: Adult; Antiviral Agents; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Male; Middle Aged; Treatment Outcome

2018
Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
    Internal medicine (Tokyo, Japan), 2018, Jun-01, Volume: 57, Issue:11

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inflammation; Lamivudine; Liver Failure, Acute; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Time-to-Treatment

2018
Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.
    Antiviral therapy, 2018, Volume: 23, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Sustained Virologic Response

2018
A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B.
    Journal of Korean medical science, 2018, Feb-19, Volume: 33, Issue:8

    Topics: Adolescent; Alanine Transaminase; Antibodies, Viral; Antiviral Agents; Child; DNA, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Retrospective Studies; Treatment Outcome; Young Adult

2018
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2018, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult

2018
Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir.
    Molecular medicine reports, 2018, Volume: 17, Issue:5

    Topics: Antiviral Agents; Biological Transport; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Multidrug Resistance-Associated Proteins

2018
Efficacy of entecavir-based rescue therapy in lamivudine-resistant chronic hepatitis B patients in China: a retrospective study.
    Die Pharmazie, 2018, 04-02, Volume: 73, Issue:4

    Topics: Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2018
Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:2

    Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; China; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Telbivudine; Thymidine; Virus Activation; Virus Replication

2018
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
    Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018

    Topics: Adenine; Adult; Antiviral Agents; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Nucleosides; Organophosphonates; Outpatients; Prognosis; Prospective Studies; Recurrence; Risk Factors; RNA, Viral; Telbivudine; Time Factors; Treatment Outcome; Withholding Treatment

2018
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment.
    Biological trace element research, 2019, Volume: 188, Issue:2

    Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult

2019
Long-term results of chronic hepatitis B antiviral treatment with nucleos(t)ide analogues: a single center experience.
    Minerva gastroenterologica e dietologica, 2019, Volume: 65, Issue:1

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Telbivudine; Tenofovir; Young Adult

2019
Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy.
    Saudi medical journal, 2018, Volume: 39, Issue:10

    Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Tenofovir

2018
Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
    Clinical and translational gastroenterology, 2018, 11-12, Volume: 9, Issue:11

    Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Virus Activation; Young Adult

2018
High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
    Medicine, 2019, Volume: 98, Issue:1

    Topics: Adult; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Early Detection of Cancer; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleosides; Retrospective Studies; Risk Factors; Telbivudine

2019
Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; China; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine

2019
Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:11

    Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Middle Aged; Nucleosides; Organophosphonates; Prognosis

2019
Long-term data on entecavir treatment for treatment-naive or lamivudine-resistant chronic hepatitis B infection in kidney transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:5

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplant Recipients

2019
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection.
    Hepatology (Baltimore, Md.), 2020, Volume: 71, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunomodulation; Interferon-alpha; Interleukin-10; Interleukin-12; Lamivudine; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Nucleosides; Organophosphonates; Proto-Oncogene Proteins c-akt; Tenofovir

2020
Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.
    Journal of gastroenterology, 2020, Volume: 55, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Drug Evaluation, Preclinical; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B virus; Humans; In Vitro Techniques; Inhibitory Concentration 50; Lamivudine; Protein Biosynthesis; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stilbenes; Virus Replication

2020
Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Latin America; Male; Middle Aged; Retrospective Studies; Rituximab; Seroconversion; Transplant Recipients; Virus Activation

2020
Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors.
    BMC infectious diseases, 2020, Mar-18, Volume: 20, Issue:1

    Topics: Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hypothalamic Neoplasms; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Steroids; Virus Activation

2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
    Gut, 2020, Volume: 69, Issue:12

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Sustained Virologic Response; Tenofovir

2020
Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization.
    Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:7

    Topics: Antigens, Surface; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation

2020
Combination of saikosaponin c and telbivudine synergistically enhances the anti-HBV activity.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2020, Volume: 69, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hep G2 Cells; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Oleanolic Acid; Saponins; Telbivudine

2020
A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Antiviral Agents; DNA Damage; DNA, Mitochondrial; Drug Synergism; Guanine; Heme Oxygenase-1; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon Regulatory Factor-3; Interferon Type I; Lamivudine; Membrane Proteins; Mice; Mice, Transgenic; Peptide Fragments; Phagosomes; Signal Transduction; Telomerase; Virus Replication

2020
Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
    Clinical and molecular hepatology, 2020, Volume: 26, Issue:3

    Topics: Adenine; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Telbivudine; Tenofovir

2020
Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.
    Revista espanola de enfermedades digestivas, 2020, Volume: 112, Issue:11

    Topics: Antiviral Agents; Glomerulonephritis, Membranous; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Treatment Outcome

2020
Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.
    Bioorganic & medicinal chemistry, 2021, 01-01, Volume: 29

    Topics: Acrylamide; Antiviral Agents; Drug Design; Drug Resistance; Gene Expression Regulation; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lamivudine; Molecular Docking Simulation; Mutation; Protein Binding; Protein Conformation; Structure-Activity Relationship; Virus Replication

2021
Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
    Antiviral research, 2021, Volume: 189

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Mutation; Nucleosides; Nucleotides; Organophosphonates; Phylogeny; Telbivudine; Viral Load; Virus Replication

2021
Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors.
    Leukemia & lymphoma, 2021, Volume: 62, Issue:9

    Topics: Antiviral Agents; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Treatment Outcome

2021
A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:3

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; North America; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult

2021
Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients.
    BMC infectious diseases, 2021, Sep-06, Volume: 21, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Treatment Outcome; Viral Load

2021
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
    Annals of hematology, 2022, Volume: 101, Issue:3

    Topics: Adult; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Virus Activation; Young Adult

2022
Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B virus; Humans; Lamivudine; Retrospective Studies; Treatment Outcome

2022